The Neurobiology le Genetics ea Mathata a ho Laola Mosi oa Matla: Likamano le Lithethefatsi Tsa Lithethefatsi (2008)

LITLHAHISO: Hlahloba ka ho hlaka ho hlakisa OCD litlamong tsa boitšoaro.


E hatisitsoe Inthaneteng 2007 July 3. doi:  10.1016 / j.bcp.2007.06.043

PMCID: PMC2222549 NIHMSID: NIHMS37091
Judson A. Brewer, MD PhD le Marc N. Potenza, MD ea PhD
Moetso oa khatiso oa ho qetela oa mohatisi o fumaneha ho Biochem Pharmacol
Sheba lihlooho tse ling ho PMC hore Qotsa sehlooho se hatisitsoeng.

Eya ho:

inahaneloang

IMathata a taolo ea mpulse (ICDs), ho kenyelletsa papali ea chelete ea ho becha, trichotillomania, kleptomania le tse ling, ho nahanoa hore li ka robala ka bongata bo qobelloang. Lintlha tsa morao-rao li bontšitse hore mathata ana a ka nkuoa a lemalla. Mona re lekola metheo ea liphatsa tsa lefutso le methapo ea kutlo ea mathata a taolo ea tšusumetso mme re nahane ka mathata a kahara meralo ena e sa amaneng ka ho felletseng.

Selelekela

Matšoenyeho a Taolo ea Tšusumetso

Mathata a tloaelehileng a taolo ea tšusumetso ea maikutlo (ICDs) ao ho nang le litekanyetso tsa tlhahlobo ho Diagnostic and Statistical Manual (DSM-IV-TR) a kenyelletsa papali ea chelete ea papali ea chelete (PG), kleptomania, pyromania, boloetse ba ho phatloha ba nakoana, trichotillomania le ICD tse sa hlalosoang ka tsela e 'ngoe [1]. Ho hlahisitsoe mekhoa ea li-ICD tse ling (ho qobella ho reka, ho sebelisa marang-rang ka mathata, boitšoaro bo hlephileng ba thobalano, le ho khetha letlalo ka mokhoa o qobelloang)2, 3]. Litšobotsi tsa mantlha tsa li-ICD li kenyelletsa ho kenya letsoho khafetsa kapa ho qobella boits'oaro bo itseng (mohlala, ho becha, ho hula moriri) leha ho bile le litlamorao, taolo e fokotsehileng holima boits'oaro bo nang le mathata, le tsitsipano kapa takatso ea takatso ea maikutlo pele o kenella boitšoarong [2].

Li-ICD le Bokhoba

Li-ICD li 'nile tsa nahanoa hore li ka robala holim'a pherekano e sa nkeheng maikutlo [4], e emelang mathata a pharalletseng a qobelloang a qobelloang (OC) [5, 6]. Le ha batho ba nang le li-ICD ba etsa boits'oaro bo pheta-phetoang, hangata ba e-na le litakatso tse matla tse amanang, boits'oaro hangata bo amana le bo khahlisang kapa bo khahlisang, athe boits'oaro kapa litloaelo tse pheta-phetoang ho OC disorder (OCD) hangata li egodystonic [7, 8]. Batho ba nang le li-ICD hangata ba fumana mehato e phahameng ea ho se ts'oenyehe le tse ling tse amanang le tsona tse kang ho batla maikutlo empa batho ba nang le OCD hangata ba fumana lintlha tse phahameng tsa ho qoba likotsi [8-12]. Mekhoa ea ho lemoha li-ICD joalo ka PG li kopana le tse amanang le ts'ebeliso ea lithethefatsi, ka litekanyetso tse ikhethileng tse amanang le mamello, ho hula, ho leka makhetlo a sa atleheng ho fokotsa kapa ho tlohela, le ho kena-kenana le likarolo tse kholo tsa bophelo bo sebetsang [1]. Joalokaha ho hlalositsoe ka tlase, ho na le ho tšoana ho hongata ha methapo ea kutlo le liphatsa tsa lefutso lipakeng tsa li-ICD le lithethefatsi. Kahoo, li-ICD li ka nkuoa e le "ho lemalla boitšoaro"[13-16].

Bokhoba: Kakaretso

Ho entsoe lipatlisiso tse batsi mabapi le metheo ea methapo ea kutlo ea nts'etsopele le tlhokomelo ea lithethefatsi (e hlahlobisitsoe ho [17-19]). Maikutlo a hlahang a bokhoba ba tahi a kenyelletsa sethethefatsi kapa boits'oaro bo fumanang boiphihlelo ka ho matlafatsa, ka liphetoho tse latelang ka mekhoa ea ho ithuta e iputsitseng meputsong hore e be tloaelo kapa boitlamo.19].

Boemo ba ho ba le takatso ea boithapollo ke taba ea bohlokoa maemong a pele a ts'ebeliso ea lithethefatsi. Boemo ba tlholisano, bo hlalosoang e le "ts'ebetso eo ka eona meputso e mecha e ithutoang le ho fumana boits'oaro bo matlafatsang," e kenyelletsa maemo a tikoloho a amanang haufi le nako le lits'ebetso tsa ho lemalla [20]. Lits'ebetso tse 'maloa tsa neuroanatomical tse bohlokoa ts'ebetsong ena ea maemo li kenyelletsa amygdala, e bohlokoa ho abeng bohlokoa ba maikutlo le mekhatlo e ithutoang lipakeng tsa tšusumetso e amehang le e sa nke lehlakore.17, 21], orbitofrontal cortex (OFC), eo lithutong tsa liphoofolo e khothalelitsoeng ho kenyelletsa litebello tsa sephetho le ka likhokahano tsa eona tse matla tsa anatomiki le basolateral amygdala (BLA) e ka tsamaisa thuto e kopaneng ho amygdala, le anterior cingulate cortex (ACC) eo e kentsoe letsoho ho ithuteng ka khethollo le taolo ea kutloisiso [22]. Meetso e meng ea bohlokoa ts'ebetsong ena e kenyelletsa hippocampus, e fanang ka mohopolo oa maemo a amanang le tšusumetso ea ts'usumetso, le li-hypothalamic le septal nuclei, tse fanang ka tlhaiso-leseling e amanang le boits'oaro ba khale ba ts'usumetso joaloka ho khanna ka thobalano le ho kenella ka limatlafatsi [23, 24]. Hammoho, likarolo tsena le tse amanang le tsona li na le methapo ea methapo e amanang le boits'oaro ba boits'oaro. Ha boits'oaro bo matlafatsang bo ntse bo ipeha tlaase ho ba amanang le lithethefatsi nakong ea ts'ebetso ea ts'ebeliso ea lithethefatsi, ho kanna ha etsahala hore liphetoho sebopehong le ts'ebetsong ea libaka tsena li kenya letsoho ho kenelleng ho fetelletseng mekhoeng ea boits'oaro e bohareng ba li-ICD.

E bohlokoa hape maemong le ho lemalleng ke li-nucleus accumbens (NAcc), e nang le khetla le konokono. Khetla, ka tsela e ikhethileng ea ho itšireletsa le sebaka sa karoloana ea moea, e bohlokoa molemong oa ho tsitsisa botsitso, athe mantlha e ameha haholo ho bonts'eng boits'oaro bo ithutoang ho arabela lits'oants'o tse bolelang liketsahalo tse ts'oanang le ts'ehetso / matlafatso ea maemo [17, 19]. Sebaka sa ventral tegmental area (VTA), se nang le likhakanyo tsa dopaminergic ho amygdala, NAcc le prefrontal cortex (PFC, e kenyeletsang OFC le ACC), e thusa mekhatlo e ithutileng ka liketsahalo tse khothatsang ka phasic dopamine (DA) [25, 26]. Dopaminergic neurons lia thibeloa, mohlomong ka thorsus medial thalamus (habenula), ha meputso e lebelletsoeng e sa etsahale [27, 28]. Ho 'nile ha etsoa tlhahiso ea hore mokhahlelong oa ho qetela oa bokhoba ba tahi, tšusumetso e kholo litlamong tsa boits'oaro bo tsoang lipotong tsa corticostriatal tse kenyelletsang ventral striatum ho li-circuits tse kenyelletsang dorsal striatum, eo esale e ameha ho thehoeng ha litloaelo (bona ka tlase) [29, 30].

Ho sebelisa striatum e le ho tsepamisa maikutlo, ho ka hlahisoa mohlala oo ho oona boemo ba takatso ea botona bo qalang ho shell ea NAcc ka litlatsetso tse tsoang ho hippocampus, VTA (eo le eona e fumanang thuso ho tsoa khubung ea mantlha ea amygdala), le PFC, "liphetoho" ho maemo matlafatso mokokotlong oa NAcc ka litlatsetso tse tsoang ho BLA le PFC, 'me qetellong e fetoha sebopeho sa tloaelo ho dorsal striatum ka ho kenya letsoho ho tsoa ho sensorimotor cortices le libaka tse ling tse kang septal hypothalamus [19, 23]. Liphetoho tsena li kenyelletsa libaka tsa limbic, associative le sensorimotor tsa striatum, ka ho latellana (bona palo 1A). Dorsal striatum le globus pallidus (ka ho kenya letsoho ho tsoa mokokotlong oa NAcc) li sebetsa ho thalamus e ntan'o iphelisa ka likarolo tsa cortical. Ka har'a sebopeho sena sa anatomiki, liphatsa tsa lefutso le neurobiology ea li-ICD lia hlahlojoa. Ntle le moo, leha ho na le ho kenella ho hoholo ha neurocircuitry le neurotransmitter ho kenella maemong a fapaneng a tahi, lits'ebetso tsena li hlahisoa ka tatellano e batlang e ts'oana le sebopeho sa phetoho se boletsoeng kaholimo.

Setšoantšo sa 1Setšoantšo sa 1Setšoantšo sa 1  

a: Ho potoloha ha boko ho amehang bokhobeng. PFC = preortal cortex, VTA = sebaka sa karoloana ea moea, SN = substantia nigra, NAcc = nucleus accumbens, OFC = orbitofrontal cortex

Lipalo tsa batho ba nang le lithethefatsi le li-ICD

Ha e le hantle liphatsa tsa lefutso li fana ka tlatsetso ea pele ts'ebetsong ea bokhoba ba tahi, kaha li supa bofokoli ba mantlha bakeng sa lits'ebetso tse tloaelehileng tsa boits'oaro. Liphuputso tsa liphatsa tsa lefutso tsa li-ICD li fana ka maikutlo a ho ts'oana le lithethefatsi tse ling [31]. Liphuputso tsa malapa le mafahla tsa lefu la seoa li hakantse hore menehelo ea lefutso e ikarabella ho 60% ea phapang e leng kotsing ea ho lemalla lithethefatsi [32, 33]. Ka mokhoa o ts'oanang menehelo e matla ea liphatsa tsa lefutso e fumanoe bakeng sa PG. Ho sebelisoa lintlha tse tsoang ho ngoliso ea Vietnam Era Twin (VET), lintlha tsa lefutso li hakantsoe hore li ikarabella lipakeng tsa 35% le 54% ea mokoloto oa matšoao a DSM-III-R ho PG [34]. Tekanyo ea boiphihlelo e ts'oana le ea mafu a mang a kelello ho kenyeletsoa mathata a ts'ebeliso ea lithethefatsi: ho sampole e ts'oanang, 34% ea phapang e kotsing ea ts'ebeliso ea lithethefatsi e bakiloe ke liphatsa tsa lefutso [35]. Phuputso e 'ngoe ea ngoliso ea VET e lekotseng nalane ea bophelo bohle ea PG le ts'ebeliso ea joala ka tlhahlobo e hlophisitsoeng mme e lekantse boholo ba kotsi ea tikoloho le liphatsa tsa lefutso tsa PG e arolelanoang le ts'epahalo ea joala. Bangoli ba fumane hore karolo e kholo ea kotsi bakeng sa tleliniki ea PG (12-20% ea liphatsa tsa lefutso le 3-8% ea tikoloho) e tlalehiloe ke kotsi ea ts'ebeliso ea joala [36]. Phuputsong e ileng ea latela ea baahi ba tšoanang, Slutske le basebetsi-'moho le bona ba fumane kamano e kholo lipakeng tsa PG le boits'oaro bo sa tsotelleng, mme mokhatlo ona o hlalosoa haholo ke liphatsa tsa lefutso [37]. Liphuputso tsena li fana ka maikutlo a hore li-ICD tse kang PG li amana le ho itšetleha ka joala le boits'oaro bo sa tsotelleng sechaba, 'me li ka hokahanngoa ka litsela tse tloaelehileng tse kang ho qhekella (bona ka tlase). Le ha e le tsa pele, tlhaiso-leseling ena e fana ka maikutlo a hore joalo ka lithethefatsi tsa lithethefatsi, mabaka a liphatsa tsa lefutso a kenya letsoho haholo ho pathophysiology ea li-ICD. Menehelo e ikhethileng ea lefutso e amanang le li-neurotransmitters tse amehang ho li-ICD e hlalositsoe ka tlase.

Ho se tsitsisehe

Ho se tsotelle ho amana le mathata a mangata a kelello, ho kenyeletsoa li-ICD le lithethefatsi tsa lithethefatsi [38]. Nakong ea ts'ebetso ea ho lemalla lithethefatsi, ho se ts'oanehe ho kenya letsoho mehatong ea pele joalo ka liteko tsa lithethefatsi. Tšoaneleho e na le likarolo tse ngata; Mohlala, phuputso e 'ngoe e supile likarolo tse' ne (ho potlaka, ho hloka tekanyetso, ho hloka mamello, le ho batla maikutlo.39]) athe mehato e meng e hlophisitsoeng ea ho hlohlelletsoa ho etsa likarolo tse tharo (likarolo tsa Barratt Impulsivity Scale li ba likarolo tsa ts'ebeliso, tsa motlakase le tsa moralo le sekhahla sa khatello ea maikutlo sa Eysenck hore e be libaka tse ikhethileng, tsa ho potlaka le tsa kutloelo-bohloko [40, 41]). Moeller le basebetsi-'moho le eena ba hlalositse ho se ts'oane le maikutlo e le "mokhoa o lebisang liphellong tse potlakileng, tse sa reroang ho tšusumetso ea kahare kapa kantle [ka ho fokotseha] mabapi le litlamorao tse mpe tsa karabelo ena ho motho ea potlakileng kapa ho ba bang [42]. ” Hammoho, liphuputso tsena li fana ka maikutlo a ho se ts'oenyehe ke moaho o rarahaneng, o nang le likarolo tse ngata. Ka mokhoa o ts'oanang, tlhaiso-leseling e tsoang liphuputsong tsa batho le tsa liphoofolo e fana ka maikutlo a hore libaka tse ngata tsa boko le sistimi ea methapo ea kutlo li kenya letsoho ho itšoareng hampe nakong ea ts'ebeliso e mpe ea lithethefatsi32, 43].

Dopamine, Impulsivity le li-ICD

Joalokaha ho hlalositsoe kaholimo, dopamine e bohlokoa molemong oa ts'ebeliso ea bokhoba ba tahi le lintlheng tse ling hamorao. Sistimi ea Dopaminergic e kentsoe letsoho ho se ts'oenyeheng le li-ICD. Li-psychostimulants tse kang amphetamine e susumetsa dopamine le litsamaiso tse ling tsa biogenic mme ke mekhoa ea kalafo e sebetsang bakeng sa khaello ea khatello ea maikutlo (ADHD), lefu le nang le tšusumetso e le karolo ea mantlha. Ts'oaetso ea sistimi ea NAcc DA e kentsoe letsoho ho ADHD [44]. Sistimi ea Dopaminergic le eona e kenya letsoho lits'ebetsong tse lemalloang. Ho fumaneha ho sa feleng ha D2 receptor ho boetse ho tlalehiloe ho batho ba hlekefetsang k'hok'heine likhoeli tse 'maloa kamora ho tlosa' mele, mme ho fumaneha hona ho amahanngoa le ho fokotseha ha metabolism ho OFC har'a libaka tse ling tsa boko joalo ka cingulate gyrus [18, 45]. Mehato ea mantlha ea motheo ea phumaneho ea mokelikeli oa DA D2 ea ho fumana lithethefatsi lihloohong tse sa lemalloang e bolela esale pele hore methylphenidate e rata lithethefatsi, e ts'ehetsa khopolo-taba ea hore ho fumaneha ha li-receptor tse tlase tsa D2 ho hokahanya ho ba kotsing ea ho lemalla lithethefatsi [46]. Ho ts'ehetsa, phokotso ea phallo ea receptor ea D2 (mohlomong ka lebaka la ho fokotseha ha linomoro tsa li-receptor ho fapana le ho eketseha ha DA) e ile ea bonoa ho ventral striatum ea likhoto tse matla haholo, mme ho fumaneha hona ho ne ho bolela esale pele litekanyetso tse phahameng tsa boits'oaro ba "cocaine" e kenang methapong [47]. Ho fumaneha ha li-receptor tse tlase tsa D2 ho striatum ho boetse ho boletse esale pele hore ts'ebeliso ea "cocaine" e eketsehileng e tla latela ke litšoene [48]. Boholo boo liphuputso tsena li amanang le ho se ts'oenyehe le li-ICD li hloka tlhahlobo e tobileng.

DA e ka kena lipakeng ho putsa kapa ho matlafatsa likarolo tsa papali ea chelete, mme DA e kentsoe letsoho ho PG [49]. Maemo a fokotsehileng a DA le keketseho ea eona ea metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) le homovanillic acid (HVA) li fumanoe ho CSF ​​ea batho ba bapalang papali ea chelete [50], leha liphuputso tsena li ne li se li sa bonoe ha ho lokisoa sekhahla sa phallo ea CSF [51]. Amphetamine, sethethefatsi se eketsang li-catecholamine tse kantle ho lisele le 5-HT ka pherekano ea vesicular, thibelo ea reuptake, ntlafatso ea synthesis ea DA, le thibelo ea monoamine oxidase (MAO) [52], litefiso tse fapaneng bakeng sa boitšoaro ba papali ea chelete ho batho ba nang le bothata ba papali ea chelete, empa eseng bakeng sa tšebeliso ea joala ho batho ba noang bothata [53]. Liphuputso tsena li fana ka maikutlo a karolo ea DA (le / kapa litsela tse ling tsa aminergic) ho pathophysiology ea PG kaha lithethefatsi tse nang le mekhoa e ts'oanang ea ts'ebetso li ka feta pele bakeng sa ho khutlisetsoa ha lithethefatsi tse ling sehlopheng seo (ke hore amphetamine bakeng sa k'hok'heine) [54, 55].

Litlaleho tse 'maloa li hokahantse tšebeliso ea agonist ea DA ho Lefu la Parkinson (PD) le PG le boits'oaro bo bong ba ICD joalo ka libakeng tsa thobalano le ho ja [56-60]. Phuputso ea haufinyane ea bakuli ba PD ba 272 ba ileng ba hlahlojoa le ho hlahlojoa bakeng sa li-ICD ba fumane mekhatlo e ts'oanang e matla ho li-agonists tsa DA tse nang le PG le li-ICD tse ling [61]. Nalane ea ICD pele PD e qala e ne e amahanngoa le ICD ea hajoale. Litekanyetso tsa letsatsi le letsatsi tsa levo-dopa li lekana le bakuli ba nang le ICD ho feta ba se nang. Phuputso e lebelletsoeng ea bakuli ba 297 ba nang le PD ba hlahlobetsoeng ho ata ha bophelo ba PG e boetse e fumane setsoalle lipakeng tsa ts'ebeliso ea agonist ea DA le PG [62]. Le ha ho ne ho se mokhatlo o neng o bonoa le agonist subtype, mokhatlo o tsamaisanang le tsamaiso ea levodopa ka nako e le 'ngoe o ile oa bonoa, o fana ka maikutlo a phello ea tekanyetso e felletseng kapa phello ea pele ea levodopa [62]. Kahoo, tlhaiso-leseling e seng e le teng e fana ka maikutlo a hore li-agonists tsa DA, haholo-holo ho batho ba kotsing ea li-ICD, li amahanngoa le PG le li-ICD tse ling, hape li hokahanya sistimi ea DA le li-ICD.

Liphuputso tsa lefutso li hokahantse liphatsa tsa lefutso tse 'maloa le ho se ts'oenyehe le ho lemalla lithethefatsi, ho kenyeletsoa le liphatsa tsa lefutso tse kenyelletsang mokamo oa DA D4DRD4le mopalami oa DA (SLC6A3) [32, 63, 64ADHD e fumaneha haholo, 'me menehelo ea liphatsa tsa lefutso e bakang kotsi e ka bang 80% ea lefu lena,' me har'a mefuta e amehang ka ho fetisisa ea lefutso e amanang le ADHD ke DRD4 le SLC6A3 mefuta-futa [65]. Mefuta e meng ea DA e joalo ka DRD5 e hokahantsoe le ADHD hape [65]. Lithuto tse peli li fumane mokhatlo oa li-polymorphisms tsa DRD4 le PG [66, 67]. Ntle le moo, D2A1 boemo ba kamohelo ea D2 bo kentse letsoho ts'ebelisong e mpe ea lithethefatsi, ho ja hampe le ho tsuba63, 68], mme e fumanoe ka makhetlo a mabeli a phahameng lithutong tse nang le PG ha e bapisoa le litsamaiso [69]. Lintlha tse boletsoeng kaholimo li fana ka maikutlo a hore liphatsa tsa lefutso le tlhahiso e sebetsang, menehelo ea dopaminergic ho likarolo tse susumetsang tsa li-ICD le lithethefatsi tse ling. Leha ho le joalo, ho hlokahala lithuto tse ling ho pheta-pheta le ho holisa liphuputso tsena, haholo ha ho etsoa lipatlisiso tsa menehelo ea DA ho mehato ea botho ea ho se ts'oanelehe kapa ho aha likhopolo tse amanang le thuto e kang ho batla lintho tse ncha ho bontšitse liphetho tse fapaneng kamanong ea bona le liphatsa tsa lefutso tsa DA [70].

Molao oa Dopaminergic le li-ICD: Likarolo tsa γ-aminobutyric acid (GABA) le Glutamate

γ-aminobutyric acid (GABA) ke methapo ea kutlo e ka sehloohong e thibelang methapo bokong. E entsoe ka methapo ea methapo e tsoang ho glutamate ke enzyme glutamate decarboxylase. Ho na le bopaki ba khokahano ea anatomic le ts'ebetso pakeng tsa GABA le lits'ebetso tsa dopaminergic hammoho le ts'ehetso e ntseng e eketseha bakeng sa litlamorao tsa ho feto-fetoha ha litsamaiso tsa GABAergic ho mathata a ts'ebeliso ea lithethefatsi [71]. Mohlala, tiagabine, GABA reuptake inhibitor e sebelisitsoeng haholo ho phekola ho oa, e bonts'itse matla a pele ho ts'ebeliso ea koae ea cocaine [72], mme o na le tlaleho ea nyeoe, e bonts'itsoeng ho thusa ka taolo ea mabifi a sa tsitsang [73]. Glutamate, neurotransmitter e nyarosang le selelekela sa GABA le eona e kentsoe letsoho litlamong hammoho le li-ICD.

Lithutong tsa pele ho nako, litekanyetso tsa glutamate kahare ho NAcc mediate boits'oaro ba ho batla moputso [74]. Ho lokolloa ha nonvesicular glutamate ho tsoa ho cysteine ​​/ glutamate antiporters ho bonts'itsoe e le mohloli o ka sehloohong oa "glutamate" e kantle ho lisele ho NAcc; e hlophisa ho lokolloa ha vesicular glutamate le dopamine ka ho hlohlelletsa sehlopha sa glutamate 2/3 metabotropic glutamate receptors [75, 76]. N-acetylcysteine ​​(NAC), cysteine ​​pro-drug, e eketsa litekanyo tsa extracellular tsa glutamate, mohlomong ka ho hlohlelletsa li-inhibitor metabotropic glutamate receptors, ka hona e fokotsa ho tsoa ha synaptic ea glutamate. E bonts'itse matla a pele ho ts'ebeliso ea koae ea cocaine [77] le PG [78]. Ha li kopantsoe hammoho, tlhaiso-leseling ena e fana ka maikutlo a likarolo tse ka bang teng bakeng sa litsamaiso tsa glutamatergic le GABAergic litlamong tsa lithethefatsi le boits'oaro.

Serotonin, Impulsivity le li-ICD

Joalo ka DA, GABA le glutamate, karolo ea serotonin (5-HT) e ts'ehetsoa ke ho se ts'oarehe, li-ICD le lithethefatsi tsa lithethefatsi. Morero oa li-neuron tsa Serotonergic o theha mokokotlo oa "dorsal raphe" bokong ho ea libakeng tse kenyeletsang hippocampus, frontal cortex le amygdala. Mefuteng ea liphoofolo, pherekano ea forebrain 5-HT e bonts'itsoe e lebisa ho khetho e sa tsitsang, ha 5-HT agonist fenfluramine e fokotsa boits'oaro bo joalo [79, 80]. Ntle le moo, lesion ea rat raphe e baka khetho ea nakoana bakeng sa meputso e potlakileng [81]. Bahanyetsi ba khethiloeng ba 5-HT ha ba bapisoa ba bonts'itse khothaletso ea khetho ea boits'oaro [82]. Karolo ea likarolo tse ikhethileng tsa sisteme ea serotonin e tšehetsoa ke liphetho tsa ho hlohlelletsoa ho hoholo ha makoloi ho 5-HT1B litoeba tse kokotoang [83]. Tryptophan depletion, e theolelang maemo a 5-HT (ka ho fokotseha ho fokotsehang ho 5-HT metabolites ho cerebrospinal fluid (CSF)), e eketsa ho ts'oenyeha ha makoloi (lipalo tse tsoelang pele tsa liteko tse tšoanang), empa eseng khetho e potlakileng (ho lieha ho theola litheko) bathong [84, 85]. Lithutong tse nang le nalane ea lelapa ea joala, tryptophan depletion e fokotsa boits'oaro ba boits'oaro (Stop Task) empa ha ea ka ea susumetsa ho lieha ho theola84]. Maemo a tlase a 5-HT metabolite 5-hydroxyindolacetic acid (5-HIAA) a fumanoe ho batho ba nang le litšobotsi tse sa tsitsang [86, 87], le bokhoba ba tahi pele ho nako [64]. Maemo a tlase a CSF 5-HIAA le ona a hokahantsoe le boits'oaro ba ho ipeha kotsing liphoofolong; mohlala, litšoene li nka nako e teletsana ho tlola merung [88]. Ha ho kopantsoe hammoho, mela e mengata ea bopaki e tšehetsa karolo ea 5-HT ho fapakaneng ho se ts'oanehe, leha lipatlisiso tse ling li hlokahala ho khetholla likarolo tse itseng tsa sistimi ea 5-HT tse tlatsetsang likarolong tse itseng tsa ho se ts'oenyehe.

Sistimi ea 5-HT e kentsoe letsoho ho li-ICD. Le ha banna ba nang le PG khahlano le ba se nang letho ba sa bontše phapang e kholo ho 5-HT kapa 5-HIAA disampoleng tsa CSF [50, 89, 90], maemo a 5-HIAA a fumanoe a le tlase ho ba nang le PG ha ba laola bakeng sa ho tlanya nako (e ileng ea eketsoa sehlopheng sa PG) [51]. Metachlorophenylpiperazine (m-CPP), metabolite ea trazodone e sebetsa joalo ka agonist 'me e na le kamano e phahameng bakeng sa li-receptor tsa 5-HT (haholo-holo 5-HT2c, e bileng le karolo ho kenellelaneng ha likarolo tsa maikutlo, boitšoaro ba matšoenyeho le ts'ebetso ea neuroendocrine [91]). Tsamaiso ea m-CPP e tlalehiloe e hlahisa boits'oaro bo "phahameng" le ho eketsa maemo a prolactin (ts'ebetso e nahanoang hore e buelletsoe ke postsynaptic 5-HT1A / 2A / 2C li-receptors) lihloohong tse nang le PG ha li bapisoa le lihlooho tsa taolo ntle le PG [92]. Karabelo ena ea boikokobetso e ts'oana le e tlalehiloeng ke mathata a mang ao ho ona boits'oaro ba ho nkeha maikutlo kapa bo qobelloang bo hlahelletseng, ho kenyeletsoa le bothata ba ho se tsotelle sechaba93], bothata ba moeli oa moeli [94], ts'ebeliso ea koae [95], le tšebeliso e mpe ea joala kapa ho itšepa [96].

Ntle le liphephetso tsa litlhare, lithuto tsa lefutso li kentse sistimi ea 5-HT ka ho se ts'oanelehe le li-ICD. A TPH1 (tryptophan hydroxylase 1, e kenyeletsang enzyme bakeng sa mohato o lekanyetsang sekhahla tlhahiso ea 5-HT) phapang ea liphatsa tsa lefutso e fumanoe e amahanngoa le ho fokotsa 5-HIAA ho CSF ​​le boits'oaro ba ho ipolaea ho batlōli ba molao ba mabifi [97]. Liphatsa tse ling tsa serotonergic li hokahantsoe le ho se ts'oenyehe le ho lemalla lithethefatsi 'me li kenyeletsa SERT (SLC6A4) le MAOA [32]. Polymorphism e sebakeng sa ts'ehetso ea lefutso la motho la serotonin transporter (SLC6A4) Ho khouta mefuta e mekhutšoane le e telele ea protheine (e nang le mofuta o mokhuts'oane o hlahisang protheine e fokolang) e amahanngoa le likarolo tse 'maloa tsa psychopathology, ho kenyeletsoa neuroticism, matšoenyeho le khatello ea maikutlo.98-102], leha lithuto tsa morao-rao li hlahisitse lipotso mabapi le matla le bonnete ba mekhatlo ena [103-105]. SLC6A4 phapang e ka kenya letsoho ho li-ICD joalo ka ha mokhatlo o tlalehiloe lipakeng tsa SLC6A4 allele e khuts'oane le PG ho banna empa eseng basali106]. Kamora nako, lithuto tse amanang le mehlala e menyenyane ea lithuto li tlalehile ka mokhoa o sa lumellaneng lipakeng tsa liphatsa tsa lefutso tsa serotonin le monoamine oxidase le li-ICD tse kang PG, ho reka ka qobello le trichotillomania [107-109]. Lithuto tse ling li sebelisa lisampole tse kholo le liteko tse hlokolosi (mohlala, tsa tlhahlobo) li tla thusa ho batlisisa liphatsa tsa lefutso tsa lelapa le pharalletseng la li-ICD.

Lithuto tsa kalafo ea li-serotonergic agents li hlahisitse litholoana tse fapaneng mabapi le ts'ebetso ea kalafo ea li-ICD [110-113]. Liteko tsa kliniki tse laoloang ke "placebo" tse laoloang ke "placebo" tsa li-serotonin reuptake inhibitors (SSRIs) li hlahisitse litholoana tse fapaneng, ka li-RCT tse ling li bonts'a katleho e fetang ea placebo [114, 115] le ba bang eseng [116, 117]. Liphuputso tse ngata li bontšitse ntlafatso ea bongaka pele ho kalafo lihlopheng tse phekotsoeng ka litlhare le li-placebo. Melemo ena e fana ka maikutlo a kalafo kapa karabelo ea "placebo" ho fapana le ho fumana melemo e itseng ea moriana o sebetsang, leha phapang ea morao-rao lipakeng tsa lihlopha liphuputsong tse ling e fana ka maikutlo a litlamorao tse sebetsang tsa meriana. Lithutong tse 'maloa tsa trichotillomania, ha ho phapang e kholo e bonoeng lipakeng tsa kalafo ea fluoxetine le placebo [111]. Phuputsong e sa reroang ea citalopram vs.118]. Liphuputso tse peli tsa letsoho le tšoanang, tse laoloang tsa fluvoxamine kalafong ea ho reka ka qobello ha li bontše phapang lipakeng tsa lithethefatsi tse sebetsang le placebo [119, 120], empa phuputso ea libeke tse supileng tsa citalopram e bulehileng e lateloang ke libeke tse robong tsa tlhaiso-leseling e bonts'itse ntlafatso ea sethethefatsi se sebetsang ha se bapisoa le placebo [121]. Tlaleho ea nyeoe e khothalelitse katleho ea escitalopram, le SSRI kalafong ea ts'ebeliso e nang le mathata a marang-rang, empa lithuto tse ling li hloka ho etsoa mabapi le ts'ebetso ea kalafo (le tlhahlobo) ea lefu lena [113]. Ha ho kopantsoe, liphuputso li fana ka maikutlo a hore li-SSRI li sebeletsa batho ba bang ba nang le li-ICD empa eseng ba bang. Liphuputso tsena li fana ka maikutlo a hore likarolo tse ikhethileng tsa motho ka mong (mohlala, likarolo tsa lefutso kapa mathata a kopaneng joalo ka ho tšoenyeha kapa khatello ea maikutlo) a ka thusa ho tataisa khetho ea kalafo e nepahetseng [122].

Joalokaha ho hlalositsoe kaholimo, ho se ts'oanehe ho tlatsetsa ho li-ICD le ho lemalla lithethefatsi. Ho ka etsahala hore ho se ts'oenyehe ho na le menehelo e ikhethang ho li-ICD ka bomong le ho lemalla lithethefatsi joalo ka ha ho le joalo ka likarolo tsa ts'ebetso ea ts'ebetso ea kelello [123]. Ntle le moo, joalo ka ho se ts'oenyehe, ho tšoana lipakeng tsa li-ICD le lithethefatsi li teng libakeng tse ling, joalo ka ho etsa liqeto le ho sebetsana le khatello ea maikutlo, mme libaka tsena li nkuoa ka tlase.

Tekolo ea Moputso, Ho etsa liqeto, le Ventral Prefrontal Cortex (PFC)

Hang ha boitšoaro bo fetetse ka nqane ho methati ea pele ea boithuto bo kopanetsoeng, taolo ea phethahatso holim'a ts'ebetsong ea eona e ba ea bohlokoa le ho feta. Libaka tsa PFC li kenya letsoho ho nkeng liqeto mathateng a taolo ea tšusumetso le ho lemalla lithethefatsi. OFC e supa boleng bo lekanyelitsoeng ba tšusumetso ea moputso [124, 125], ts'ebetso e karolo e buelletsoeng ke sistimi ea 5-HT. OFC e thusa ho feto-fetoha ha mohopolo ka ho khothaletsa ntlafatso ea khokahano e kopanyang libakeng tse tlase tsa boko joalo ka amygdala [126]. Ntle le moo, gyrus e ka tlase e ka pele / dorsolateral PFC e bohlokoa ho fetoleng tlhokomelo, e kenyang bokhoni ba ho hanela tlhaiso-leseling e kenang joalo ka ho nahana ka lithethefatsi / boits'oaro [127]. OFC, ho kenyeletsoa le PFC (vmPFC) e kenang kahare, e kenya letsoho ho sebetseng le ho bolela lintho esale pele [128, 129]. Bafo ba nang le liso tsa vmPFC ba bontša likhaello molemong oa ho rala, hangata ba etsa liqeto tse lebisang liphellong tse mpe [130]. Ntle le moo, lithuto tsena li sebetsa hampe ho feta ho bapisa lihlooho ho Iowa Gambling Task (IGT), mohato o ntlafalitsoeng oa ho fuputsa moputso o monyane hanghang le kotlo ea nakoana e amanang le phaello ea nako e telele khahlanong le moputso o moholo oa hanghang le kotlo ea nakoana e amanang le nako e telele- tahlehelo ea nako [131].

Lihlooho tse nang le mathata a ts'ebeliso ea lithethefatsi hangata li bonts'a ts'ebetso e mpe ho IGT [132], mme ts'ebetso ena e mpe e amana le phokotso ea phallo ea mali ho vmPFC le libaka tse ling tsa cortical [133-136]. Batho ba nang le PG le bona ba khetha hampe ha ba bapisoa le taolo ea IGT [12, 137]. Batho ba nang le PG ba khetha habonolo meputso e tlase ea chelete eo ba e ts'episitsoeng hanghang ho feta meputso e phahameng ea chelete e ts'episitsoeng kamora ho lieha nako ("ho fokotsa litheolelo") ha ho bapisoa le litaba tsa taolo [138]. Theolelo ea nakoana ea meputso e bonts'itsoe e le kapele haholo ho batho ba nang le PG ba nang le mathata a ts'ebeliso ea lithethefatsi, e lumellanang le mekhoa e tlatsetsang bothateng bo bong le bo bong ka mokhoa oa tlatsetso kapa oa tšebelisano [138]. Ho se sebetse ha lipotoloho tsa vmPFC ho ka kenya letsoho phapang ena ea boits'oaro lipakeng tsa PG le lihlooho tsa taolo, joalo ka ha ho bonahala ho le joalo ka ho lemalla lithethefatsi. Ho fokotsehile ha ts'ebetso ea vmPFC ho bonoe ho lithuto tsa PG nakong ea tlhahiso ea mekhoa ea papali ea chelete [9], ts'ebetso ea Stroop Colour-Word Interference Task [139], le papali ea chelete e etsisitsoeng [140]. Thutong ena ea ho qetela, ts'ebetso ea vmPFC e hokahane hampe le ho tiea ha papali ea chelete har'a lithuto tsa PG. Hammoho, lintlha tsena li fana ka maikutlo a karolo ea bohlokoa bakeng sa vmPFC ho PG. Lithuto tsa nako e tlang li tla thusa ho hlakisa hore na tse fumanoang li fetela ho li-ICD tse ling hakae.

Batho ba itšetlehileng ka lithethefatsi ba bontša ho se tloaelehang ho OFC. E ts'oana le batho ba nang le tšenyo ho OFC, bafo ba nang le ts'ehetso e matlafatsang ba bonts'a liqeto tse nepahetseng, ka ho nahanisisa ka nako e telele pele ho khetho ea khetho [141]. Ho fokotseha ha ts'ebetso ea OFC le cingulate gyrus ho amahanngoa le ts'ebeliso e sa foleng ea cocaine [142]. Ts'ebetso e mpe ea `` drug-word drug '' Stroop task e hokahana le hypoactivation ea OFC ho batho ba lemaletseng cocaine "142]. Ha li kopantsoe, lintlha tsena li fana ka maikutlo a hore libaka tsa PFC li bohlokoa ha ho etsoa liqeto.

Ho etsa liqeto, ho susumetsoa ke maikutlo le Amygdala

Mosebetsi oa Amygdala o kenya letsoho haholo ho etsa liqeto le ho se ts'oenyehe. Amygdala e amohela kenyelletso ea serotonergic le dopaminergic ho tsoa ho raphe le VTA ka tatellano, mme ts'ebetso ea eona e laoloa ke tekano lipakeng tsa nyakallo e susumetsoang ke glutamate le thibelo ea GABA-mediated [143, 144]. Amygdala e nka karolo ho sebetsaneng le mohopolong oa maikutlo a maikutlo. Ho latela somatic marker hypothesis (e bolelang hore ho etsa liqeto ho itšetleha ka likaroloana tsa methapo ea kutlo tse laolang homeostasis, maikutlo le maikutlo), likarabo tse matla tsa tšusumetso li hlahisoa ke likarolo tsa makoloi a visceral joalo ka hypothalamus le brain autonomic brainstem nuclei [127]. Amygdala e sebetsa 'moho le vmPFC / OFC ha ho etsoa liqeto, ha sebaka se seng le se seng se kenya letsoho ka mokhoa o fapaneng. Ka litoeba, liso tsa excitotoxic tsa BLA li khothaletsa khetho e potlakileng mosebetsing oa ho matlafatsa o liehang [145]. Ho batho, lihlooho tse nang le tšenyo ea vmPFC le lihlooho tse nang le tšenyo ea amygdalar ka bobeli li bonts'a bofokoli ba ho etsa liqeto ho IGT [146]. Leha ho le joalo, likarabo tsa boikemelo (tse lekantsoeng ke karabelo ea boits'oaro ba letlalo) ho phaello kapa tahlehelo e kholo ea chelete li haelloa ke batho ba nang le liso tsa amygdalar tse kopaneng; ka lehlakoreng le leng, likarabo tsena li nepahetse ho bakuli ba nang le tšenyo ea vmPFC [146]. Leha ho le joalo, lebelletse likarabo tsa boits'oaro ba letlalo nakong ea ts'ebetso ea IGT li bonts'a mokhoa o fapaneng: lihlooho tse nang le ts'enyo ea vmPFC li bontša bofokoli, athe tse nang le ts'enyo ea amygdalar li bonts'a likarabo tse tloaelehileng. Hammoho, liphuputso tsena tse etsahalang ka mokhoa o sa tloaelehang oa amygdala-ventral striatum li ka susumetsa ho se ts'oenyehe lits'ebetsong tse lemalloang, mohlomong ka lebaka la tšusumetso ea boleng ba khothatso ea lits'oants'o [148]. Ho batho ba lemaletseng lithethefatsi, likarabo tse fetelletseng tsa boipuso li bakoa ke litlhahiso tsa lithethefatsi [149]. Ketsahalo e sa tloaelehang ea amygdalar e ka susumetsoa ke mefuta e fapaneng ea liphatsa tsa lefutso liphatseng tsa 5-HT100]. Karolo ea amygdala ho li-ICD ha e so batlisisoe ka kotloloho.

Tloaelo ea Tloaelo

Ha boits'oaro bo fetoha ho tloha ho ithuteng ka mafolofolo ho ea karabong e tloaelehileng, taolo e fetoha ho tsoa marang-rang a kopaneng a cortico-basal ganglia a kenyelletsang PFC le ventral striatum ho ea dorsomedial striatum / caudate ebe ho ea marang-rang a sensorotor cortico-basal ganglia a amanang le dorsolateral striatum / putamen ( bona Setšoantšo sa 1b) [29]. Ho tlatlapa boitšoaro ho fetola ts'ebetso ho tloha ho dorsolateral PFC mme ho isa ho putamen le motor cortices [150, 151]. Ka bokhoba ba tahi, ho ipusa ka makhetlo a mangata ha litšoene ho amana le tsoelo-pele ea ts'ebetso ea ventral striatum ho kenella ho dorsal striatum [152]. Ha boits'oaro bo se bo tloaela, bo susumetsoa ke maemo, likarolo tsa bohlokoa tsa ts'ebeliso ea ts'ebeliso ea lithethefatsi, li ka baka karabelo ea litloaelo ho fapana le ts'ebetso e lebisitsoeng ho sepheo [153]. Karabelo ena ea phapang e ka susumetsoa ka tsela e sa tobang ke NAcc ka likhakanyo tsa eona ho VTA / substantia nigra e nang le tlatsetso e latelang ea dopaminergic ho tloha ho ea morao ho ea marangrang a sensorimotor [154]. Ho kenella ha mohanyetsi ea kopaneng oa DA ea alpha-flupenthixol ho dorsal striatum empa eseng moahong oa NAcc ho fokotsa ts'ehetso ea cocaine e fumanehang mefuteng ea liphoofolo.155]. Tlhatlhobo e tlase ea li-receptor tsa D2 DA e bonoe pele ho ventral ebe kamora moo e ts'oaroa ke litšoene tse sebelisang k'hok'heine, ho latela maikutlo a entsoeng le batho ba hlekefetsang batho ba sa foleng ba cocaine.156, 157].

Li-ICD li hlalositsoe ho latela mokhoa oa ho itloaetsa [158]. Joalo ka ho lemalla lithethefatsi, ho senyeha ha lipotoloho tse tsoaloang hoa ameha mathateng ana. Mohlala, phuputsong ea papali ea chelete e etsisitsoeng, batho ba nang le PG ba bonts'itse liphapang tsa ts'ebetso ea ts'ebetso ea ho tsoala ha e bapisoa le litaba tsa taolo, mme ts'ebetso e ne e amana le ho tiea ha papali ea chelete [140]. Lintlha tsa pele le tsona li kenyelletsa ts'ebetso ea pelehi litakatsong tsa papali ea chelete ho PG le litakatsong tsa cocaine tse itšetlehileng ka koae [159]. Bophahamo ba putamenal bo fokotsehileng bo bonoe lihloohong tse nang le trichotillomania ha e bapisoa le lihlooho tsa taolo, leha bohlokoa ba ts'ebetso ea phapang ena ea anatomiki bo hloka lipatlisiso tse ling [160]. Ho tsoa boitsebisong bona, khopolo-taba e ka hahuoa hore liketso tse tataisoang ke sepheo li fetela ho tloha ho ithuteng ka mafolofolo ho ea karabong e sa sebetseng, e itloaetseng ho li-ICD ka mokhoa o ts'oanang le o bonoang ke batho ba lemaletseng lithethefatsi.

Boikarabello ba khatello ea maikutlo le li-ICD

Liketsahalo tse sithabetsang le khatello ea maikutlo khafetsa li kenya letsoho ho khutlela ts'ebelisong ea lithethefatsi har'a batho ba nang le ts'ebeliso ea opiate le cocaine [161, 162]. Bopaki ba bongaka bo bontšang hore khatello ea maikutlo e matla e lebisa ho eketseha hoa taolo ea hau ea lithethefatsi tse kang amphetamines [163], cocaine [164, 165] le joala [166, 167]. Mekhoa e amanang le khatello ea maikutlo e bohlokoa molemong oa ho qala lithethefatsi le ho ata ha tsona joalo ka mathata a sa foleng [168]. Ho pepesetsoa khatello ea maikutlo ho hlahisa boemo bo eketsehileng ba ho tsoha le ho tšoana le lithethefatsi ka botsona [169]. Lithethefatsi tse 'maloa tsa tlhekefetso, joalo ka li-psychostimulants [170-172] le joala [173] etsa hore ho be le khatello ea kelello le axPA ea HPA. Ka litoeba, li-opioid li matlafatsa selekane sa HPA, empa litlamorao tse fapaneng li bonoa liphoofolong tse nyane, ho kenyeletsoa le batho (tse hlahlojoang ho [174]). Ho feta moo, li-benzodiazepine li bontšitsoe ho fokotsa ts'ebetso ea HPA bathong [175] Ha ts'ebetso ea axPA ea HPA e eketsa phetisetso ea mesolimbic dopamine, ho pepesehela khatello ea maikutlo ho ka fana ka karoloana e tloaelehileng ea methapo eo khatello ea maikutlo e ntlafatsang boitšoaro ba ho batla lithethefatsi [169]. Likhatello tse amanang le khatello ea maikutlo, joalo ka thibelo le tšitiso, li eketsa tokollo ea NAcc DA [176, 177]. Ho ba le khatello ea maikutlo e bakoang ke khatello ea maikutlo ho batho ba lemaletseng kalafo ba kenya ts'ebetsong striatum le ho fokotsa ts'ebetso ea ts'ebetso ho anterior cingulate. Liphuputso tsena li fana ka maikutlo a karolo ea khatello ea maikutlo ts'ebetsong ea pele ho ts'ebetso le ho nka karolo ka nako e le 'ngoe ea lipotoloho tsa tloaelo ho lemalla [178]. Hore na liphetoho tsena li amana hakae le ho se ts'oane le / kapa ho nka liqeto tse seng ntle ho hloka lipatlisiso tse ling [179].

Liphuputso tsa batho ba nang le li-ICD li hlahisitse liphetho tse fapaneng mabapi le ho nka karolo ha litsela tsa khatello ea maikutlo mathateng ana [180]. Mohlala, maemo a CSF a corticotrophin-releasing hormone (CRH) a ne a sa fapane lithutong tse nang le PG ha a bapisoa le litsamaiso [89]. Keketseho ea nakoana ea cortisol e hlokometse liphuputsong tsa papali ea chelete ea baithaopi ba thaothoang likasinong ba nang le bothata ba papali ea chelete ba bonts'ang boholo bo ts'oanang ba karabelo ho taolo [181-183]. Liketsahalo tse sithabetsang tsa bophelo joalo ka ts'itiso e mpe ea bophelo ba pele li kentsoe ho PG joalo ka ha ba le lemalla lithethefatsi [177]. Hammoho, tlhaiso-leseling ena e fana ka maikutlo a hore ho tla ba bohlokoa ho lekola mekhoa e tobileng eo khatello ea maikutlo le eona e tlatsetsang ho pathophysiology ea li-ICD.

Li-opioids, khatello ea maikutlo le li-ICD

Li-opioid li hlophisa mesolimbic DA litseleng tsa VTA ka ho kenya ts'ebetsong li-opioid receptors ho li-interneuron tsa bobeli tse bakang hyperpolarization le thibelo ea GABA ho lokolloa li-neuron tsa mantlha (li-dopaminergic output neurons) ka lebaka leo ho eketsoa ha DA ho eketsehileng [184]. Leha ho le joalo, ts'ebetso ea li-κ opioid receptors ho li-neuron tsa mantlha e baka tšitiso ea bona e tobileng [185]. Haufinyane ho bonts'itsoe hore opioid receptor activation (κ vs. μ) ka mokhoa o fapaneng e thibela mesolimbic neurons ho latela lipheo tsa bona tsa sepheo (Nacc vs. BLA) [186]. Sisteme ea opioid e ts'oarellang, ka μ le κ opioid receptors, e thibela tonis ea HPA ka mokhoa o khahlisang, e fana ka maikutlo a hore karabelo ea tlhaho e tlatselletsa ho lemaleng.32]. Ho tšehetsa khopolo-taba ena, litoeba tse haelloang ke mu opioid receptor gene (OPRM1) a se ke a bontša morphine analgesia kapa khetho ea sebaka [187].

Polymorphisms ka OPRM1 di amahanngwa le phapano e tlamang ho di-endorphin (ka mohlala, dikhoutu tse fapaneng tsa A118G tsa seamohedi se tlamang le ho kenya tshebetsong ha protheine ya sona ya G e kopantsweng le ka hare e lokisang kanale ya potasiamo [188]). Mofuta o fapaneng oa A118G o amahanngoa le ts'epahalo ea opioid [32], 'Me lihlooho tse nang le mofuta ona li bontšitse likarabo tse ntle ho naltrexone bakeng sa kalafo ea ts'ebeliso ea joala [64, 189]. Haplotypes ea lefutso la kappa opioid receptor (OPRK1) le sebaka se khothalletsang selelekela sa eona sa pele sa ligand, prodynorphin, le sona se amahanngoa le ts'epahalo ea opiate le lithethefatsi tse ling [33].

Ho becha kapa boits'oaro bo amanang le tsona bo 'nile ba amahanngoa le maemo a phahameng a mali a opioid ea ho qetela β-endorphin [190]. Ha ba fuoa mekhoa ea bona ea tšebetso [191] le katleho ea kalafo ea joala le ts'ebeliso ea joala [192], bahanyetsi ba li-opioid receptor ba 'nile ba hlahlojoa kalafong ea li-ICD. Naltrexone e bonts'itse bophahamo ba placebo thutong ea sebaka se le seng sa PG [193], le nalmefene, mohanyetsi oa nako e telele oa opioid, o bonts'itse bophahamo ba placebo thutong e kholo e foufetseng habeli, e shebaneng haholo le lithuto tsa PG [194]. Naltrexone e bonts'itse molemo molemong oa lithuto tsa boits'oaro bo qobelloang ba thobalano [195] le liteko tse ngoliloeng ka bolokolohi tsa batloli ba thobalano ba lilemong tsa bocha [196]. Naltrexone e bonts'itse matla a pele ho ho reka ka qobello [121]. Lintlha tsena li fana ka maikutlo a hore, lits'ebetso tsa opioid li bohlokoa litlamong tsa lik'hemik'hale le boits'oaro. Ha li-opioid li susumetsa marang-rang a mangata a methapo le litsela tse amanang le khatello ea maikutlo, lithuto tsa nako e tlang li kanna tsa hlalosa mekhoa ea bona e nepahetseng ea ts'ebetso ho li-ICD.

Liphetho le Litataiso tsa Nako e Tlang

Lintlha tse hlahang mabapi le neurobiology ea ho se ts'oarehe le li-ICD li fana ka maikutlo a tšoanang le a lithethefatsi tsa lithethefatsi. Leha liphuputso tse fokolang li fupulitse li-ICD ho feta tse lemalloang ke lithethefatsi (mme lithuto tse ngata tse seng li le teng li batlisitse PG), data ea liphatsa tsa lefutso, boits'oaro le kalafo e ama litsamaiso tse ngata tsa methapo ea kutlo le lipotoloho tsa neuronal ho theheng le ho hlokomeleng bokhoba ba boitšoaro. Leha ho na le khatelo-pele ena, likhang li ntse li le teng mabapi le nosology le pathophysiology ea mantlha ea li-ICD tse itseng.

Li-endophenotypes li fana ka leseli ho etiology ea mathata mme tlhaiso-leseling e joalo e ka tsebisa likarolo tsa mathata. Maikutlo a Endophenotypic a mafu a kelello a joalo ka khatello ea maikutlo le schizophrenia a ntse a hlaha [197, 198]. Li-endophenotypes ke "likarolo tse ka bonoang tse sa bonoeng ke leihlo le le leng" mme e kanna ea ba neuropsychological, endocrinological, cognitive, neuroanatomical kapa biochemical ka tlhaho. Li-endophenotypes li tsebisa kutloisiso ea liphatsa tsa lefutso tse bakang ts'oaetso ea mafu ka ho tsepamisa maikutlo ho likarolo tse ikhethileng tsa bioloji ho fapana le likarolo tsa tlhatlhobo ea mafu a kelello tseo hangata li fapaneng ka tlhaho198]. Ha tse ling li ntse li tsebahala ka sebopeho le semelo sa li-ICD, maikutlo a endophenotypic a likarolo tsa ona tsa mantlha a ka hlaha. Mohlala, ho se ts'oenyehe, likarohano tsa endocrine ho khatello ea maikutlo, kapa likarolo tsa eona li ka emela li-endophenotypes tsa bohlokoa bakeng sa PG, li-ICD tse ling le lithethefatsi tsa lithethefatsi. Ho khetholla li-endophenotypes ho lokela ho thusa ho khetholla likaroloana tsa mathata (tse ipapisitseng le liphatsa tsa lefutso le tse ling), qetellong li hlompha sebopeho, tlhahlobo le kalafo e nepahetseng. Liphetoho tsa mehato e ts'oanang ea endophenotypic li kanna tsa lebelloa hore li tsamaee le ntlafatso ea matšoao bakeng sa li-ICD le lithethefatsi tsa lithethefatsi. Li-endophenotypes tse amanang le bongaka li ka tataisa nts'etsopele ea mefuta ea liphoofolo ea mafu ana e tla qetella e re thusitse ho utloisisa etiology ea li-ICD le lithethefatsi tsa lithethefatsi, ho theha maano a sebetsang a thibelo le ho ntlafatsa mekhoa ea kalafo ea boits'oaro le litlhare.

lumela hore baa fokola

Re rata ho leboha Ngaka Christopher Pittenger ka tlhahlobisiso ea hae e phethahetseng le litlhaloso tse thusang mabapi le buka ena e ngotsoeng ka letsoho. Ts'ehetso ea lipatlisiso tsena e fanoe ke thuso ea NIH ea T32-MH19961 Thupelo ea Patlisiso ea Kliniki ea Neuroscience ho Psychiatry (JAB), Setsi sa Phuputso sa Varela Grant (JAB), Setsi sa Naha sa Tlhekefetso ea Lithethefatsi se R01-DA019039 (MNP) le R01- DA020908 (MNP), Patlisiso ea Basali ea Bophelo Yale (MNP), le VA VISN1 MIRECC (MNP) le REAP (MNP).

Mongolo o botlaaseng ba leqephe

Boitlhotlhollo ba Mohoeletsi: Ena ke faele ea PDF ea mongolo o ngotsoeng ka letsoho o sa amoheloang o amoheletsoeng bakeng sa ho hatisoa. Joaloka tšebeletso ho bareki ba rona re fana ka phetolelo ena ea pele ea mongolo o ngotsoeng ka letsoho. Mongolo o ngotsoeng ka letsoho o tla ba le ho kopitsa, ho kenya lihlopha le ho hlahloba bopaki bo hlahang pele o hatisoa ka mokhoa oa oona oa ho qetela. Ka kopo hlokomela hore nakong ea mekhoa ea tlhahiso ea lihlahisoa e ka fumanoa e ka amang litaba, le litsebiso tsohle tsa molao tse sebetsang koranteng e amanang le eona.

References

1. Komiti ea Mokhatlo oa American Psychiatric ka Nomenclature le Statistics. Buka ea ho hlahloba le ea Statistical ea Mathata a kelello. 4. Washington, DC: Mokhatlo oa Maiketsetso oa Amerika; 2000.
2. Fana ka J, Potenza MN. Mathata a taolo ea tšusumetso: litšoaneleho tsa bongaka le taolo ea litlhare. Ann Clin Psychiatry. 2004;16: 27-34. [E fetotsoe]
3. Fana ka JE, Potenza MN. Likarolo tse qobelloang tsa mathata a ho laola maikutlo. Litliliniki tsa mafu a kelello tsa Amerika Leboea. 2006;29(2): 539-51. x. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
4. McElroy SL, Hudson JI, Mopapa H, Jr, Keck PE, Jr, Aizley HG. Mathata a taolo ea tšusumetso ea DSM-III-R eseng libakeng tse ling a khethiloeng: litšobotsi tsa kliniki le kamano le mathata a mang a kelello. Am J Psychiatry. 1992;149(3): 318-27. [E fetotsoe]
5. Hollander E, Wong CM. Mathata a ho shebella a qobelloang. J Clinic Psychiatry. 1995;56(Suppl 4): 3-6. puisano 53-5. [E fetotsoe]
6. Hollander E, Wong CM. Boloetse ba 'mele ba "dysmorphic", "papali ea chelete", le litakatso tsa thobalano. J Clinic Psychiatry. 1995;56(Suppl 4): 7-12. puisano 13. [E fetotsoe]
7. Fana ka J, Potenza MN. Likarolo tse qobelloang tsa mathata a ho laola maikutlo. Phekolo ea mafu a kelello N Am. ka khatiso.
8. Blaszczynski A. Papali ea papali ea chelete le mathata a ho qobella motho ho a shebella. Psychol Rep. 1999;84(1): 107-13. [E fetotsoe]
9. Potenza MN, Steinberg MA, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, le al. Ho becha ho khothaletsa ho becha hoa mafu: thuto e sebetsang ea ho nka litšoantšo tsa matla a khoheli. Arch Gen Psychiatry. 2003;60(8): 828-36. [E fetotsoe]
10. Mohlankana Kim S, Grant JE. Litekanyo tsa botho bothateng ba ho becha le ho kula ho feteletseng. Patlisiso ea Psychiki. 2001;104(3): 205-212. [E fetotsoe]
11. Petry NM. Matšoao a kelello bothateng ba ho becha le ba sebelisang hampe bothata ba papali ea chelete. American Journal mabapi le Lithethefatsi. 2000;9(2): 163-171. [E fetotsoe]
12. Cavedini P, Riboldi G, Keller R, Annucci A, Bellodi L. Ho se sebetse ha lobe ka pele ho bakuli ba papali ea chelete. Likokoana-hloko tsa likokoana-hloko. 2002;51(4): 334-341. [E fetotsoe]
13. Potenza M. Na Mathata a Tlhekefatsang a ka kenyelletsa maemo a amanang le lithethefatsi? Mathata. 2006;101(suppl 1): 142-51. [E fetotsoe]
14. Shaffer HJ. Batsoali ba makatsang: pono e hlokolosi ea papali ea chelete le ho lemalla. Mathata. 1999;94(10): 1445-8. [E fetotsoe]
15. Holden C. 'Boitšoaro': na li teng? Saense. 2001;294(5544): 980-2. [E fetotsoe]
16. Grant JE, Brewer JA, Potenza MN. Matšoao a phekolo ea methapo ea methapo ea boitšoaro. CNS spectrums. 2006;11(12): 924-30. [E fetotsoe]
17. Kalivas PW, Volkow ND. Motheo oa bokhoba ba ho lemalla: mokhoa oa tšusumetso le khetho. Am J Psychiatry. 2005;162(8): 1403-13. [E fetotsoe]
18. Volkow ND, Fowler JS, Wang GJ. Boko ba kelello ba motho ea lemaletseng bo shebelletsoe ke leseli la lithuto tsa monahano: lipotoloho tsa boko le maano a kalafo. Neuropharmacology. 2004;47(Suppl 1): 3-13. [E fetotsoe]
19. Khale BT, Robbins TW. Litsamaiso tsa Neural tsa matlafatso ea ts'ebeliso ea lithethefatsi: ho tloha liketsong ho ea ho tloaelo. Nat Neurosci. 2005;8(11): 1481-1489. [E fetotsoe]
20. Martin-Soelch C, Linthicum J, Ernst M. Boemo ba ho ba le takatso ea maikutlo: Lits'ebeletso tsa Neural le se boleloang ke psychopathology. Litsebi tsa thuto ea kelello le litlhaloso tsa likokoana-hloko. 2007;31(3): 426-40. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
21. Everitt BJ, Mok'hadinale RN, Parkinson JA, Robbins TW. Boitšoaro ba ho rata lintho: tšusumetso ea mekhoa e itšetlehileng ka amygdala ea ho ithuta ka maikutlo. Liphatlalatso tsa New York Academy of Science. 2003;985: 233-50. [E fetotsoe]
22. Parkinson JA, Mok'hadinale RN, Everitt BJ. Limbic cortical-ventral striatal system e tlasa maemo a ho ferekana. Tsoelo-pele lipatlisisong tsa boko. 2000;126: 263-85. [E fetotsoe]
23. Likamore R, Taylor JR, Potenza MN. Nts'etsopele ea methapo ea maikutlo ea ts'usumetso bocheng: Nako e mahlonoko ea ts'oaetso ea bokhoba. Am J Psychiatry. 2003;160: 1041-1052. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
24. Swanson LW. Cerebral hemisphere regulation ea boitšoaro bo susumetsoang. Lipatlisiso tsa boko. 2000;886(12): 113-164. [E fetotsoe]
25. Mirenowicz J, Schultz W. Bohlokoa ba ho sa lebelloe bakeng sa likarabo tsa moputso ho li-neurone tsa dopamine tsa primate. Sengoloa sa neurophysiology. 1994;72(2): 1024-7. [E fetotsoe]
26. Likhopolo tsa Schultz W. likhopolo tsa boitšoaro bo mabapi le moputso. Tlhahlobo ea selemo le selemo ea psychology. 2006;57: 87-115. [E fetotsoe]
27. Christoph GR, Leonzio RJ, Wilcox KS. Tsosoloso ea laten habenula e thibela li-neuron tse nang le dopamine sebakeng sa substantia nigra le ventral tegmental ea rat. Leqephe la Neuroscience. 1986;6(3): 613-9. [E fetotsoe]
28. Ullsperger M, ea Cramon DY. Phoso ea ho lekola ho sebelisa maikutlo a kantle: likarolo tse ikhethileng tsa moetlo oa habenular, sistimi ea moputso, le sebaka sa cingate sa makoloi se senotsoeng ke litšoantšo tse sebetsang tsa matla a khoheli. Leqephe la Neuroscience. 2003;23(10): 4308-14. [E fetotsoe]
29. Yin HH, Knowlton BJ. Karolo ea basal ganglia ho itloaetseng tloaelo. Tlhahlobo ea tlhaho. 2006;7(6): 464-76. [E fetotsoe]
30. Biler RD, Volkow ND. Bokhoba ba lithethefatsi: neurobiology ea boitšoaro bo sitisang boitšoaro. Mekhoa ea Phekolo ea Limolek'hule. 2006;12(12): 559-566. [E fetotsoe]
31. Lobo DS, Kennedy JL. Liphatsa tsa lefutso tsa papali ea chelete le litloaelo tsa boitšoaro. CNS spectrums. 2006;11(12): 931-9. [E fetotsoe]
32. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Litšusumetso tsa lefutso ho ho susumetsa, ho beha likotsi, ho arabela ka khatello le ho ba kotsing ea ts'ebeliso e mpe ea lithethefatsi le ho lemalla. Tlhaho ea tlhaho. 2005;8(11): 1450-7. [E fetotsoe]
33. Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA. Pharmacogenetics le liphatsa tsa lefutso tsa limolek'hule tsa batho tsa lithethefatsi tsa opiate le cocaine le kalafo ea bona. Tlhahlobo ea meriana. 2005;57(1): 1-26. [E fetotsoe]
34. Eisen SA, Lin N, Lyons MJ, Scherrer JF, Griffith K, 'Nete ea' Nete, et al. Litšusumetso tse tloaelehileng tsa boitšoaro ba papali ea chelete: tlhahlobo ea mafahla a 3359. Mathata. 1998;93(9): 1375-84. [E fetotsoe]
35. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, Nete W, Lin N, et al. Litšusumetso tsa lefutso ho ts'ebeliso e mpe ea lithethefatsi le DSI-III-R ts'ebeliso e mpe ea lithethefatsi: phuputso ea mafahla a 3,372. Am J Med Genet. 1996;67(5): 473-7. [E fetotsoe]
36. Slutske WS, Eisen S, 'nete WR, Lyons MJ, Goldberg J, Tsuang M. Kotsi e tloaelehileng ea liphatsa tsa lefutso ea ho becha le ho itšetleha ka joala ho banna. Arch Gen Psychiatry. 2000;57(7): 666-73. [E fetotsoe]
37. Slutske WS, Eisen S, Xian H, 'Nete ea' Nete, Lyons MJ, Goldberg J, et al. Phuputso ea mafahla ea kamano lipakeng tsa papali ea chelete le boloetse ba botho. Tlaleho ea psychology e sa tloaelehang. 2001;110(2): 297-308. [E fetotsoe]
38. Evenden JL. Mefuta e fapa-fapaneng ea ho susumetsoa. Psychopharmacology. 1999;146(4): 348-61. [E fetotsoe]
39. Mokha oa SP, Lynam DR. Mohlala oa Mefuta e Mehlano le ho se ts'oenyehe: Ho sebelisa sebopeho sa sebopeho sa motho ho utloisisa ho se ts'oarehe. Botho le Phapang ea Motho ka mong. 2001;30(4): 669-689.
40. Patton JH, Stanford MS, Barratt ES. Sebopeho sa likarolo tsa sekhahla sa Barratt impulsiveness. Tlaleho ea psychology ea bongaka. 1995;51(6): 768-74. [E fetotsoe]
41. Eysenck SB, Eysenck HJ. Ts'oaetso le boits'oaro bo botle: boemo ba bona tsamaisong ea sebopeho sa tlhaloso ea botho. Litlaleho tsa kelello. 1978;43(3 Pt 2): 1247-55. [E fetotsoe]
42. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Mehopolo ea kelello ea ho susumetsoa ke matla. Am J Psychiatry. 2001;158(11): 1783-93. [E fetotsoe]
43. Mok'hadinale RN, Winstanley CA, Robbins TW, Everitt BJ. Limbic corticostriatal system le ho lieha ho matlafatsoa. Liphatlalatso tsa New York Academy of Science. 2004;1021: 33-50. [E fetotsoe]
44. Sagvolden T, Sajene JA. Khaello ea tlhokomelo / khatello ea kelello-ho tloha ho likotsi tsa boko ho ea boits'oarong. Ho etsa lipatlisiso tsa boko ba boits'oaro. 1998;94(1): 1-10. [E fetotsoe]
45. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, le al. Phumano e fokotsehileng ea dopamine D2 receptor e amahanngoa le phokotso e ka pele ea metabolism ho batho ba hlekefetsang k'hok'heine. 2. Moq. 14. Synapse; New York, NY: 1993. maq. 169-77.
46. Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ, le al. Brain DA D2 receptors li bolela esale pele ho matlafatsa litlamorao ho tse susumetsang batho: ho ithuta ho ipheta. 2. Moq. 46. Synapse; New York, NY: 2002. maq. 79-82.
47. Dalley JW, Fryer TD, Brichard L, Robinson ESJ, Theobald DEH, Laane K, le al. Nucleus Accumbens D2 / 3 Receptors e Bolela Tšobotsi ea Ts'oaetso le Khokahano ea Cocaine. Saense. 2007;315(5816): 1267-1270. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
48. Moetapele MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, et al. Setšoantšo sa PET sa li-receptor tsa dopamine D2 nakong ea taolo e sa foleng ea cocaine litšoene. Nat Neurosci. 2006;9(8): 1050-1056. [E fetotsoe]
49. DeCaria C, Begaz T, Hollander E. Serotonergic le noradrenergic mosebetsing oa papali ea chelete. Libaka tsa CNS. 1998;3(6): 38-47.
50. Bergh C, Eklund T, Sodersten P, Nordin C. E fetoletse dopamine ts'ebetsong ea papali ea chelete. Medy Psychol. 1997;27(2): 473-5. [E fetotsoe]
51. Nordin C, E T. E fetotse CSF 5-HIAA dospositon ho banna ba papali ea papali ea chelete. Libaka tsa CNS. 1999;4(12): 25-33. [E fetotsoe]
52. Sulzer D, Sonders MS, Poulsen NW, Galli A. Mekhoa ea neurotransmitter e lokolloang ke amphetamines: Tlhahlobo. Tsoelo-pele ho Neurobiology. 2005;75(6): 406-433. [E fetotsoe]
53. Zack M, Poulos CX. Amphetamine primes tšusumetso ea ho becha le marang-rang a amanang le papali ea chelete ho batho ba nang le bothata ba papali ea chelete. Neuropsychopharmacology. 2004;29(1): 195-207. [E fetotsoe]
54. Shalev U, Grimm JW, Shaham Y. Neurobiology ea ho khutlela ho Heroin le ho Batla Cocaine: Tlhahlobo. Pharmacol Rev. 2002;54(1): 1-42. [E fetotsoe]
55. Loba P, Stewart SH, Klein RM, Blackburn JR. Ho sebelisoa hampe ha likarolo tsa lipapali tsa standard lottery terminal (VLT): litlamorao ho batho ba papali ea papali ea chelete le bao e seng ba mafu. J ho bapala liithuti. 2001;17(4): 297-320. [E fetotsoe]
56. Tlhaloso ea Weintraub D, Potenza MN. Mathata a ho laola tšusumetso lefung la Parkinson. Litlaleho tsa hona joale tsa neurology le neuroscience. 2006;6(4): 302-6. [E fetotsoe]
57. Kurlan R. Ho holofatsa boits'oaro bo pheta-phetoang lefung la Parkinson. Mov Disord. 2004;19(4): 433-7. [E fetotsoe]
58. Driver-Dunckley E, Samanta J, Stacy M. Pathological papali ea chelete e amanang le kalafo ea dopamine agonist lefung la Parkinson. Neurology. 2003;61(3): 422-423. [E fetotsoe]
59. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Papali ea chelete e bakoang ke lithethefatsi tse sebelisetsoang ho phekola mafu a Parkinson. Arch Neurol. 2005;62(9): 1377-1381. [E fetotsoe]
60. Szarfman A, Tonakholo ea Doraiswamy, Tonning JM, Levine JG. Kamano lipakeng tsa Papali ea papali ea chelete le Phekolo ea Parkinsonia joalo ka ha e fumanoe Lefapheng la Liketsahalo tse Ntle tsa Tsamaiso ea Lijo le Lithethefatsi. Arch Neurol. 2006;63(2): 299a – 300. [E fetotsoe]
61. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, le al. Mokhatlo oa tšebeliso ea dopamine agonist e nang le mathata a ho laola maikutlo ho lefu la Parkinson. Li-Archives tsa neurology. 2006;63(7): 969-73. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
62. Voon V, Hassan K, Zurowski M, Duff-Canning S, ea Souza M, Fox S, le al. Ho ata ha monyetla oa papali ea papali ea chelete le mokhatlo oa meriana lefung la Parkinson. Neurology. 2006;66(11): 1750-2. [E fetotsoe]
63. Haile CN, Kosten TR, Kosten TA. Liphatsa tsa lefutso tsa dopamine le tlatsetso ea eona ho lemalleng koae. Boitšoaro ba liphatsa tsa lefutso. 2007;37(1): 119-45. [E fetotsoe]
64. Kreek MJ, Nielsen DA, LaForge KS. Liphatsa tsa lefutso tse amanang le bokhoba ba tahi: bokhoba ba tahi, joala le koae. Moriana oa Neuromolecular. 2004;5(1): 85-108. [E fetotsoe]
65. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, le al. Li-Etiologic subtypes tsa ho haelloa ke tlhokomelo / bothata ba ho se sebetse hantle: ho nahana ka boko, limolek'hule tsa lefutso le tikoloho le mohopolo oa dopamine. Tlhahlobo ea Neuropsychology. 2007;17(1): 39-59. [E fetotsoe]
66. Perez de Castro I, Ibanez A, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J. Phuputso ea mokhatlo oa liphatsa tsa lefutso lipakeng tsa papali ea chelete le mofuta o sebetsang oa DNA polymorphism ho lefutso la D4. Pharmacogenetics. 1997;7(5): 345-8. [E fetotsoe]
67. Ho tla DE, Gonzalez N, Wu S, Gade R, Muhleman D, Saucier G, et al. Boithuto ba 48 bp bo pheta polymorphism ea lefutso la DRD4 ka boits'oaro bo sa tsitsang, bo qobelloang le bo lemalloang: Tourette syndrome, ADHD, papali ea chelete ea papali ea chelete le tšebeliso e mpe ea lithethefatsi. Am J Med Genet. 1999;88(4): 358-68. [E fetotsoe]
68. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Ho tla DE. Dopamine D2 receptor gene mefuta e fapaneng: boithuto ba kamano le khokahano ka boits'oaro ba ho qobella-ho lemalla. Pharmacogenetics. 1995;5(3): 121-41. [E fetotsoe]
69. Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, Chiu C, et al. Phuputso ea gene ea dopamine D2 receptor papaling ea papali ea chelete. Pharmacogenetics. 1996;6(3): 223-34. [E fetotsoe]
70. Gelernter J, Kranzler H, Coccaro E, Siever L, New A, Mulgrew CL. Li-alleles tsa D4 dopamine-receptor (DRD4) le mokhoa o mocha oa ho batla linthong tse itšetlehileng ka lithethefatsi, bothata ba botho le lihlooho tsa taolo. Am J Hum Genet. 1997;61(5): 1144-52. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
71. Sofuoglu M, Kosten TR. Maano a hlahang a meriana mabapi le ho loantša bokhoba ba koae. Maikutlo a litsebi ka lithethefatsi tse hlahang. 2006;11(1): 91-8. [E fetotsoe]
72. Gonzalez G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, et al. Tšebeliso ea meriana ea gabapentin khahlanong le tiagabine bakeng sa ho fokotsa tšebeliso ea k'hok'heine har'a bakuli ba tšoaroang ke methadone ba tšoeroeng ke methadone. Ho itšetleha ka lithethefatsi le joala. 2007;87(1): 1-9. [E fetotsoe]
73. Kaufman KR, Kugler SL, Sachdeo RC. Tiagabine ho Tsamaiso ea Postencephalitic Epilepsy le Impulse Control Disorder. Sethoathoa le Boitšoaro. 2002;3(2): 190-194. [E fetotsoe]
74. McFarland K, Lapish CC, Kalivas PW. Pele ho glutamate e hlahisang bokaholimo ba khubu ea methapo ea methapo e kenyelletsa boitokisetso ba bocha ba ho ts'oara lithethefatsi. Leqephe la Neuroscience. 2003;23(8): 3531-7. [E fetotsoe]
75. Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. Tšimoloho le tšebetso ea methapo ea kutlo ea vivo nonsynaptic glutamate. Leqephe la Neuroscience. 2002;22(20): 9134-41. [E fetotsoe]
76. Hu G, Duffy P, Swanson C, Ghasemzadeh MB, Kalivas PW. Taolo ea phetiso ea dopamine ka metabotropic glutamate receptors. Lingoloa tsa pharmacology le lingaka tsa liteko. 1999;289(1): 412-6. [E fetotsoe]
77. Larowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, le al. Polokeho le mamello ea N-acetylcysteine ​​ho batho ba itšetlehileng ka cocaine. Am J Ho lemalla. 2006 Jan-Feb;15(1): 105-10. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
78. Grant JE, Kim SW, Odlaug BL. N-Acetyl Cysteine, Moemeli oa Glutamate-Modulating, ho Phekolo ea Papali ea Chelete ea Patalo: A Pilot Study. 2007 [E fetotsoe]
79. Poulos CX, Parker JL, Le AD. Dexfenfluramine le 8-OH-DPAT e etsisa ho se ts'oanehe molemong oa ho lieha ho putsa: litlamorao tsa ngollano le tšebeliso ea joala. 1996;7(4): 395-399. [E fetotsoe]
80. Mobini S, Chiang TJ, Al-Ruwaitea AS, Ho MY, Bradshaw CM, Szabadi E. Phello ea ho felisoa ha 5-hydroxytryptamine bohareng ba khetho ea nakoana: tlhahlobo ea bongata. Psychopharmacology. 2000;149(3): 313-8. [E fetotsoe]
81. Bizot J, Le Bihan C, Puech AJ, Hamon M, Thiebot M. Serotonin le mamello ea ho lieha ha moputso ka likhoto. Psychopharmacology. 1999;146(4): 400-12. [E fetotsoe]
82. Evenden JL, Ryan CN. Pharmacology ea boits'oaro bo sa tsitsang ho likhoto: litlamorao tsa lithethefatsi ho khetho ea karabelo ka ho lieha ho fapaneng ha matlafatso. Psychopharmacology. 1996;128(2): 161-70. [E fetotsoe]
83. Brunner D, Hen R.Litlhahlobo ho neurobiology ea boits'oaro bo sa tsitsang bo tsoang litoeba tsa serotonin receptor knockout. Liphatlalatso tsa New York Academy of Science. 1997;836: 81-105. [E fetotsoe]
84. Crean J, Richards JB, de Wit H.Phello ea ho felloa ke matla ha tryptophan ka boits'oaro bo sa tsitsang ba banna ba nang le nalane ea lelapa kapa ba se nang eona. Ho etsa lipatlisiso tsa boko ba boits'oaro. 2002;136(2): 349-57. [E fetotsoe]
85. Walderhaug E, Lunde H, Nordvik JE, Landro NI, Refsum H, Magnusson A. Ho theola serotonin ka ho felloa ke matla ka potlako ha tryptophan ho eketsa ho tsilatsila ho batho ba tloaelehileng. Psychopharmacology. 2002;164(4): 385-91. [E fetotsoe]
86. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Mokelikeli o tlase oa cerebrospinal fluid 5-hydroxyindoleacetic acid mahloriso a khetholla ho susumetsoa ke boitšoaro bo mabifi bo sa nkeheng. Bophelo Sci. 1983;33(26): 2609-14. [E fetotsoe]
87. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, le al. Lithuto tsa Serotonergic ho bakuli ba nang le mathata a amanang le botho. E tsamaisana le boits'oaro ba ho ipolaea le ho ba mabifi. Arch Gen Psychiatry. 1989;46(7): 587-99. [E fetotsoe]
88. Mehlman PT, Higley JD, Faucher I, Lilly AA, Taub DM, Vickers J, et al. Lits'oants'o tse tlase tsa CSF 5-HIAA le mabifi a maholo le taolo e sa sebetseng ea litšoene tse seng tsa botho. Koranta ea Amerika ea psychiatry. 1994;151(10): 1485-91. [E fetotsoe]
89. Roy A, Adinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V le ba bang. Papali ea chelete. Phuputso ea psychobiological. Arch Gen Psychiatry. 1988;45(4): 369-73. [E fetotsoe]
90. Roy A, De Jong J, Linnoila M. Extraversion ho batho ba bapalang papali ea chelete. E tsamaellana le li-index tsa ts'ebetso ea noradrenergic. Arch Gen Psychiatry. 1989;46(8): 679-81. [E fetotsoe]
91. Kennett GA, Curzon G. Bopaki ba hore hypophagia e bakoang ke mCPP le TFMPP e hloka li-receptor tsa 5-HT1C le 5-HT1B; hypophagia e bakoang ke RU 24969 e hloka feela li-receptor tsa 5-HT1B. Psychopharmacology (Berl) 1988;96(1): 93-100. [E fetotsoe]
92. Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E. Serotonin ho se sebetse ho batho ba nang le papali ea papali ea chelete: ho eketsa karabo ea prolactin ho molomo oa m-CPP khahlanong le placebo. CNS spectrums. 2006;11(12): 956-64. [E fetotsoe]
93. Moss HB, Yao JK, Panzak GL. Boikarabello ba Serotonergic le boits'oaro ba boits'oaro bo sa sebetseng le ts'ebeliso e mpe ea lithethefatsi. Biol Psychiatry. 1990;28(4): 325-38. [E fetotsoe]
94. Hollander E, De Caria C, Stein D, Simeon D, Cohen L, Hwang M, le al. Karabelo ea boits'oaro ho m-CPP. Biol Psychiatry. 1994;35(6): 426-7. [E fetotsoe]
95. Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C. Teko ea phephetso ea meta-chlorophenylpiperazine ho batho ba lemaletseng koae: likarabo tsa lihormone le tsa kelello. Phekolo ea mafu a kelello. 1997;41(11): 1071-86. [E fetotsoe]
96. Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M. Ethanollike thepa ea serotonergiceme agonist m-chlorophenylpiperazine ho bakuli ba sa foleng ba joala. Arch Gen Psychiatry. 1991;48(4): 383. [E fetotsoe]
97. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC, le al. Letšoao la liphatsa tsa lefutso la tryptophan hydroxylase bakeng sa ho ipolaea le joala. Li-Archives tsa mafu a kelello a akaretsang. 1998;55(7): 593-602. [E fetotsoe]
98. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, le al. Mokhatlo oa litšobotsi tse amanang le matšoenyeho tse nang le polymorphism sebakeng sa taolo ea liphatsa tsa lefutso tsa serotonin. Saense. 1996;274(5292): 1527-31. [E fetotsoe]
99. Lesch KP, Gutknecht L. Pharmacogenetics ea mopalami oa serotonin. Tsoelo-pele ho Neuro-Psychopharmacology le Biological Psychiatry. 2005;29(6): 1062-1073. [E fetotsoe]
100. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, le al. Serotonin e fetisang liphatsa tsa lefutso le karabelo ea amygdala ea motho. Saense. 2002;297(5580): 400-3. [E fetotsoe]
101. Surtees PG, Wainwright NWJ, Willis-Owen SAG, Luben R, Day NE, Flint J. Social Adversity, Serotonin Transporter (5-HTTLPR) Polymorphism le Major Depression Disorder. Likokoana-hloko tsa likokoana-hloko. 2006;59(3): 224-229. [E fetotsoe]
102. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H le ba bang. Tšusumetso ea khatello ea bophelo ho khatello ea maikutlo: tekanyetso ke polymorphism ka har'a lefutso la 5-HTT. Saense. 2003;301(5631): 386-389. [E fetotsoe]
103. Jacob CP, Strobel A, Hohenberger K, Ringel T, Gutknecht L, Reif A le ba bang. Kamano lipakeng tsa allelic phapang ea ts'ebetso ea lipalangoang tsa serotonin le neuroticism mathateng a tšoenyehileng a sehlopha sa C. Koranta ea Amerika ea psychiatry. 2004;161(3): 569-72. [E fetotsoe]
104. Willis-Owen SA, Turri MG, Munafo MR, Surtees PG, Wainwright NW, Brixey RD, le al. Transporter bolelele ba serotonin polymorphism, neuroticism, le khatello ea maikutlo: tlhahlobo e felletseng ea mokhatlo. Phekolo ea mafu a kelello. 2005;58(6): 451-6. [E fetotsoe]
105. Middeldorp CM, de Geus EJ, Beem AL, Lakenberg N, Hottenga JJ, Slagboom PE, le al. Mokhatlo o Thehiloe ke Lelapa o Hlahloba lipakeng tsa Serotonin Transporter Gene Polymorphism (5-HTTLPR) le Neuroticism, Matšoenyeho le khatello ea maikutlo. Boitšoaro ba liphatsa tsa lefutso. 2007;37(2): 294-301. [E fetotsoe]
106. Perez de Castro I, Ibanez A, Saiz-Ruiz J, Fernandez-Piqueras J. Tlatsetso ea liphatsa tsa lefutso ho papali ea chelete: kamano e ka bang teng lipakeng tsa DNA polymorphism e sebetsang ho serotonin transporter gene (5-HTT) le banna ba amehileng. Pharmacogenetics. XunUMX Jun;9(3): 397-400. [E fetotsoe]
107. Perez de Castro I, Ibanez A, Saiz-Ruiz J, Fernandez-Piqueras J. Kopano e ntle ea nako e le ngoe lipakeng tsa papali ea chelete le li-polymorphisms tsa DNA tse sebetsang ho MAO-A le liphatsa tsa lefutso tsa bapalami ba 5-HT. Mol Psychiatry. 2002;7(9): 927-8. [E fetotsoe]
108. Devor EJ, Magee HJ, Dill-Devor RM, Gabel J, Black DW. Serotonin Transporter gene (5-HTT) polymorphisms le ho reka ka qobello. Koranta ea Amerika ea liphatsa tsa lefutso tsa bongaka. 1999;88(2): 123-5. [E fetotsoe]
109. Hemmings SM, Kinnear CJ, Lochner C, Seedat S, Corfield VA, Moolman-Smook JC, le al. Liphatsa tsa lefutso tse amanang le trichotillomania – Phuputso ea mokhatlo oa taolo ea linyeoe bathong ba Afrika Boroa ba Caucasus. Koranta ea Isiraele ea mafu a kelello le mahlale a amanang le ona. 2006;43(2): 93-101. [E fetotsoe]
110. Brewer JA, Grant JE, Potenza MN. Phekolo ea Papali ea chelete e kenang. Mathata a lemalloang le kalafo ea bona. ka khatiso.
111. Fana ka JE, Odlaug BL, Potenza MN. U lemaletse ho hula moriri? Mohlala o Mong oa Trichotillomania o kanna oa ntlafatsa sephetho sa kalafo. Harv Rev Psychiki. Tobetsa. [E fetotsoe]
112. Mick TM, Hollander E. Boitšoaro bo qobelloang ba thobalano. CNS spectrums. 2006;11(12): 944-55. [E fetotsoe]
113. Liu T, Potenza MN. Tšebeliso e Mathata ea Marang-rang - Litlamorao tsa Bongaka. CNS Spectr. Tobetsa. [E fetotsoe]
114. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C.Teko ea crossover ea blind-blind blind / placebo crossover ka ho becha ha pathologic. Biol Psychiatry. 2000;47(9): 813-7. [E fetotsoe]
115. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. Phuputso e laoloang habobebe e laoloang ke ts'ebeliso le polokeho ea paroxetine kalafong ea papali ea chelete. J Clinic Psychiatry. 2002;63(6): 501-7. [E fetotsoe]
116. Fana ka JE, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens L, et al. Phekolo ea Paroxetine ea papali ea chelete ea papali ea chelete: teko e laoloang ka bongata e sa sebetseng. Int Clin Psychopharmacol. 2003;18(4): 243-9. [E fetotsoe]
117. Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. Leeto la lifofane le laoloang ka placebo la fluboxamine bakeng sa papali ea papali ea chelete. Ann Clin Psychiatry. 2002;14(1): 9-15. [E fetotsoe]
118. Wainberg ML, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, le al. Phuputso e habeli e sa boneng ea citalopram khahlanong le placebo kalafong ea boitšoaro bo hlephileng ba thobalano ho banna ba bong bo fapaneng. Journal ea mafu a mafu a kelello. 2006;67(12): 1968-73. [E fetotsoe]
119. Black DW, Gabel J, Hansen J, Schlosser S. Papiso e foufetseng habeli ea fluvoxamine khahlanong le placebo kalafong ea bothata ba ho reka bo qobelloang. Litlaleho tsa lingaka tsa mafu a kelello. 2000;12(4): 205-11. [E fetotsoe]
120. Ninan PT, McElroy SL, Kane CP, Knight BT, Casuto LS, Rose SE, le al. Phuputso e laoloang ke sebaka sa fluvoxamine kalafong ea bakuli ba rekang ka mokhoa o tlamang. Tlaleho ea psychopharmacology ea bongaka. 2000;20(3): 362-6. [E fetotsoe]
121. Bullock K, Koran L. Psychopharmacology ea ho reka ka mokhoa o qobelloang. Lithethefatsi tsa kajeno (Barcelona, ​​Spain. 2003;39(9): 695-700. [E fetotsoe]
122. Fana ka JE, Potenza MN. Phekolo ea Escitalopram ea Papali ea chelete e nang le Matšoenyeho a Kopaneng: Thutong ea Pilot ea Open-Label ka ho Khaotsa ho Foufala habeli. Int Clin Psychopharmacol. 2006;21: 203-9. [E fetotsoe]
123. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Neurocognitive e sebetsa ho papali ea chelete ea papali ea chelete: papiso le ts'ebeliso ea joala, lefu la Tourette le taolo e tloaelehileng. Bokhoba (Abingdon, England) 2006;101(4): 534-47. [E fetotsoe]
124. Daw ND, O'Doherty JP, Dayan P, Seymour B, Dolan RJ. Likarolo tsa Cortical bakeng sa liqeto tsa ho hlahloba batho. Tlhaho. 2006;441(7095): 876-9. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
125. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Moputso o sa feleng le lipontšuoa tsa kotlo ho motho ea ka lehlakoreng la motho ea ts'oarellanang. Tlhaho ea tlhaho. 2001;4(1): 95-102. [E fetotsoe]
126. Stalnaker TA, Franz TM, Singh T, Schoenbaum G. Basolateral amygdala lesions e felisa likotsi tsa morao-rao tse itšetlehileng ka litšebelisano tsa morao-rao. Neuron. 2007;54(1): 51-8. [E fetotsoe]
127. Bechara A. Ho etsa liqeto, taolo le ho lahleheloa ke matla ho hanela lithethefatsi: pono e mabapi le methapo. Nat Neurosci. 2005;8(11): 1458-63. [E fetotsoe]
128. Gottfried JA, O'Doherty J, Dolan RJ. Ho khoutu boleng ba moputso oa ponelopele ho amygdala ea motho le orbitofrontal cortex. Saense (New York, NY. 2003;301(5636): 1104-7. [E fetotsoe]
129. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, Yamawaki S. Ponelopele ea meputso ea hona joale le ea bokamoso e hira batho ba fapaneng ba hirileng likonopo tsa cortico-basal ganglia. Tlhaho ea tlhaho. 2004;7(8): 887-93. [E fetotsoe]
130. Behara A. Khoebo e kotsi: maikutlo, ho etsa liqeto le ho lemalla. J ho bapala liithuti. 2003;19(1): 23-51. [E fetotsoe]
131. Bechara A, Damasio AR, Damasio H, Anderson SW. Ho hloka kutloelo-bohloko liphellong tse tlang kamora ho senyeha ha cortex ea motho. Temoho. 1994;50(13): 7-15. [E fetotsoe]
132. Bechara A, Damasio H. Ho etsa liqeto le ho lemalla (karolo ea XNUMX): ts'ebetso e mpe ea maemo a somatic ho batho ba itšetlehileng ka lithethefatsi ha ba nahana ka liqeto tse nang le litlamorao tse mpe tsa kamoso. Neuropsychologia. 2002;40(10): 1675-89. [E fetotsoe]
133. Grant S, Contoreggi C, London ED. Ba hlekefetsang lithethefatsi ba bonts'a ts'ebetso e sa nepahalang tlhahlobong ea laboratori ea ho etsa liqeto. Neuropsychologia. 2000;38(8): 1180-7. [E fetotsoe]
134. Sebelisa tšebeliso e mpe ea lik'hemik'hale le lithethefatsi tsa batho: London ED, Ernst M, Grant S, Bonson K, Weinstein Cereb Cortex. 2000;10(3): 334-42. [E fetotsoe]
135. Adinoff B, MD ea Devous, Sr, Cooper DB, Best SE, Chandler P, Harris T, le al. Ho phomotsa phallo ea mali a tikoloho le ts'ebetso ea papali ea chelete lithutong tse itšetlehileng ka cocaine le lithuto tse bapisoang hantle. Am J Psychiatry. 2003;160(10): 1892-4. [E fetotsoe]
136. Tucker KA, Potenza MN, Beauvais JE, Browndyke JN, PC ea Gottschalk, Kosten TR. Bothata ba pherekano le ho etsa liqeto ho ts'epahalleng k'hok'heine. Biol Psychiatry. 2004;56(7): 527-30. [E fetotsoe]
137. Tanabe J, Thompson L, Claus E, Dalwani M, Hutchison K, Banich MT. Ts'ebetso ea preortal cortex e fokotsehile ho becheng le ho sebeliseng lithethefatsi ha ba etsa liqeto. 2007 [E fetotsoe]
138. Petry NM. Batho ba bapalang papali ea chelete, ba nang le mathata a ts'ebeliso ea lithethefatsi le ntle le eona, litheolelo li liehisitse meputso ka litefiso tse phahameng. J Abnorm Psychol. 2001;110(3): 482-7. [E fetotsoe]
139. Potenza MN, Leung HC, Blumberg HP, Peterson BS, Fulbright RK, Lacadie CM, le al. Thuto ea mosebetsi oa FMRI Stroop ea tšebetso ea ventromedial prefrontal cortical ho bapalami ba papali ea chelete. Am J Psychiatry. 2003;160(11): 1990-4. [E fetotsoe]
140. Reuter J, Raedler T, Rose M, Hand I, Glascher J, papali ea chelete ea Buchel C. Pathological e amana le ho fokotsa ts'ebetso ea moputso oa moputso. Nature Neuroscience. 2005;8(2): 147-148. [E fetotsoe]
141. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, le al. Likhaello tse sa arohaneng molemong oa ho etsa liqeto tsa batho ba sa foleng ba amphetamine, ba hlekefetsang opiate, bakuli ba nang le tšenyo e kholo ho preortal cortex, le baithaopi ba tloaelehileng ba felisitsoeng ke tryptophan: bopaki ba mekhoa ea monoaminergic. Neuropsychopharmacology. 1999;20(4): 322-39. [E fetotsoe]
142. Goldstein RZ, Tomasi D, Rajaram S, Cottone LA, Zhang L, Maloney T, le al. Karolo ea anterior cingate le medial orbitofrontal cortex ha ho sebetsoa lintlha tsa lithethefatsi lekhoba la cocaine. Khopolo-taba. 2007;144(4): 1153-9. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
143. Rainnie DG, Asprodini EK, Shinnick-Gallagher P. Phetiso ea thabo ho amygdala ea basolateral. Sengoloa sa neurophysiology. 1991;66(3): 986-98. [E fetotsoe]
144. Rainnie DG, Asprodini EK, Shinnick-Gallagher P. Phetiso ea thibelo ho amygdala ea basolateral. Sengoloa sa neurophysiology. 1991;66(3): 999-1009. [E fetotsoe]
145. Winstanley CA, Theobald DE, Mok'hadinale RN, Robbins TW. Likarolo tse fapaneng tsa li-basolateral amygdala le orbitofrontal cortex ka khetho e sa tsitsang. Leqephe la Neuroscience. 2004;24(20): 4718-22. [E fetotsoe]
146. Bechara A, Damasio H, Damasio AR, Lee GP. Menehelo e fapaneng ea amygdala ea motho le ventromedial prefrontal cortex ho etsa liqeto. J Neurosci. 1999;19(13): 5473-81. [E fetotsoe]
147. Bechara A. Litšitiso tsa taolo ea maikutlo kamora liso tsa kelello tse tsepameng. Tlhahlobo ea machaba ea lefu la pelo. 2004;62: 159-93. [E fetotsoe]
148. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW. Mekhoa ea ho kopanya ho lemalla le ho putsa. Karolo ea li-subsystem tsa amygdala-ventral striatal. Liphatlalatso tsa New York Academy of Science. 1999;877: 412-38. [E fetotsoe]
149. Bechara A. Neurobiology ea ho etsa liqeto: kotsi le moputso. Liseminara tsa bongaka ba bongaka. 2001;6(3): 205-16. [E fetotsoe]
150. Jueptner M, Stephan KM, CD ea Frith, DJ ea Brooks, Frackowiak RS, Passingham RE. Anatomy ea ho ithuta ka makoloi. I. cortex e ka pele le ho ela hloko liketso. Sengoloa sa neurophysiology. 1997;77(3): 1313-24. [E fetotsoe]
151. Jueptner M, CD ea Frith, Brooks DJ, Frackowiak RS, Passingham RE. Anatomy ea ho ithuta ka makoloi. II. Mekhoa e metle le ho ithuta ka liteko le liphoso Sengoloa sa neurophysiology. 1997;77(3): 1325-37. [E fetotsoe]
152. Porrino LJ, Lyons D, Smith HR, Daunais JB, Nader MA. Ts'ebetso ea Cocaine e hlahisa karolo e tsoelang pele ea likarolo tsa maoto le mekhahlelo ea sensorimotor. Leqephe la Neuroscience. 2004;24(14): 3554-62. [E fetotsoe]
153. PC ea Holland. Likamano lipakeng tsa phetisetso ea lisebelisoa tsa Pavlovian le matlafatso ea matlafatso. Leqephe la thuto ea kelello ea liteko. 2004;30(2): 104-17. [E fetotsoe]
154. Haber SN, Fudge JL, McFarland NR. Litsela tsa Striatonigrostriatal ka li-primates li theha moea o nyolohang ho tloha khetla ho ea ho dorsolateral striatum. Leqephe la Neuroscience. 2000;20(6): 2369-82. [E fetotsoe]
155. Vanderschuren LJ, Di Ciano P, Everitt BJ. Kenyelletso ea dorsal striatum ho cueine e laoloang ke cueine. Leqephe la Neuroscience. 2005;25(38): 8665-70. [E fetotsoe]
156. Goldstein RZ, Volkow ND. Bokhoba ba lithethefatsi le motheo oa eona oa motheo oa neurobiological: Bopaki ba neuroimaging ba ho kenya letsoho mokokotlong oa pele. Koranta ea Amerika ea psychiatry. 2002;159(10): 1642-52. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
157. Nader MA, Daunais JB, Moore T, Nader SH, Moore RJ, Smith HR, et al. Litlamorao tsa ho itlhokofatsa ka koae ka lits'ebetso tsa dopamine litšoeneng tsa litšoelesa: ho pepeseha pepenene le ho sa foleng. Neuropsychopharmacology. 2002;27(1): 35-46. [E fetotsoe]
158. Stein DJ, Chamberlain SR, Fineberg N. Mohlala oa ABC oa mathata a tloaelo: ho hula moriri, ho khetha letlalo le maemo a mang a stereotypic. CNS spectrums. 2006;11(11): 824-7. [E fetotsoe]
159. Potenza MN, Gottschalk C, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, le al. College ea Mathata a ho Itšepa Lithethefatsi. Orlando, FL: 2005. fMRI ea linaha tse lakatsang ho becha ha Pathological le ts'ehetso ea Cocaine.
160. O'Sullivan RL, Rauch SL, Breiter HC, Grachev ID, Baer L, Kennedy DN, le al. Mefuta e fokotsehileng ea basal ganglia ho trichotillomania e lekantsoeng ka litšoantšo tsa morphometric magnetic resonance. Likokoana-hloko tsa likokoana-hloko. 1997;42(1): 39-45. [E fetotsoe]
161. Wallace BC. Maikutlo a kelello le a tikoloho a ho khutlela mokhoeng oa batho ba tsubang koae. J Tšoara Tlhekefetso. 1989;6(2): 95-106. [E fetotsoe]
162. Bradley BP, Phillips G, Green L, Gossop M. Maemo a pota-potileng sekhahla sa pele sa tšebeliso ea opiate kamora ho tlosa 'mele. Br J Psychiatry. 1989;154: 354-9. [E fetotsoe]
163. Cabib S, Puglisi-Allegra S, Genua C, Simon H, Le Moal M, Piazza PV. Litlamorao tsa amphetamine ho its'etleha le ho putsa joalo ka ha ho senotsoe ke lisebelisoa tse ncha tsa boemo ba sebaka. Psychopharmacology (Berl) 1996;125(1): 92-6. [E fetotsoe]
164. Kalivas PW, Duffy P. Liphello tse tšoanang tsa cocaine ea letsatsi le letsatsi le khatello ea maikutlo ho mesocorticolimbic dopamine neurotransuction ho rat. Biol Psychiatry. 1989;25(7): 913-28. [E fetotsoe]
165. Ramsey NF, Van Ree JM. Ho imeloa kelellong empa eseng 'meleng ho matlafatsa ts'ebeliso ea methapo ea "cocaine" ka har'a likhoto tse se nang kelello. Resin ea Boko. 1993;608(2): 216-22. [E fetotsoe]
166. Nash JF, Jr, Maickel RP. Karolo ea axothalamic-pituitary-adrenocortical axis ts'ebetsong ea khatello ea maikutlo e bakoang ke likhoto. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(5): 653-71. [E fetotsoe]
167. Volpicelli JR. Liketsahalo tse sa laoleheng le ho noa joala. Br J Addict. 1987;82(4): 381-92. [E fetotsoe]
168. Brady KT, Sinha R. Mathata a sebelisanang kelellong le ts'ebeliso ea lithethefatsi: litlamorao tsa khatello ea kelello e sa feleng. Am J Psychiatry. 2005;162(8): 1483-93. [E fetotsoe]
169. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. Hypothalamic-pituitary-adrenal axis le likarabo tsa sympatho-adreno-medullary nakong ea litakatso tse bakoang ke khatello ea maikutlo le lithethefatsi. Psychopharmacology (Berl) 2003;170(1): 62-72. [E fetotsoe]
170. Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB. Liphello tsa koae e kenang ka har'a methapo ea mali ho plasma cortisol le prolactin ho batho ba hlekefetsang batho ka cocaine. Phekolo ea mafu a kelello. 1995;38(11): 751-5. [E fetotsoe]
171. Rivier C, Vale W. Cocaine e hlohlelletsa sephiri sa adrenocorticotropin (ACTH) ka ts'ebetso ea corticotropin-releasing factor (CRF). Lipatlisiso tsa boko. 1987;422(2): 403-6. [E fetotsoe]
172. Swerdlow NR, Koob GF, Cador M, Lorang M, Hauger RL. Likarolo tsa axis tsa pituitary-adrenal li arabela ho amphetamine e matla ho rat. Pharmacology, phekolo ea likokoana-hloko le boitšoaro. 1993;45(3): 629-37. [E fetotsoe]
173. Mendelson JH, Ogata M, Mello NK. Mosebetsi oa Adrenal le joala. Serum cortisol. Moriana oa Psychosomatic. 1971;33(2): 145-57. [E fetotsoe]
174. Sarnyai Z, Shaham Y, Heinrichs SC. Karolo ea Karolo e Lokollang ea Corticotropin ho Lemalleng Lithethefatsi. Pharmacol Rev. 2001;53(2): 209-244. [E fetotsoe]
175. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Liphetoho ho plasma melatonin le cortisol kamora phirimana ea tsamaiso ea alprazolam bathong. Chronobiology machaba. 1993;10(3): 205-13. [E fetotsoe]
176. Imperato A, Angelucci L, Casolini P, Zocchi A, Puglisi-Allegra S.Liphihlelo tse pheta-phetoang tse sithabetsang li ama phallo ea limbic dopamine nakong ea khatello ea maikutlo le kamora 'ona. Lipatlisiso tsa boko. 1992;577(2): 194-9. [E fetotsoe]
177. McCullough LD, Salamone JD. Ho kenyeletsoa ha nucleus accumbens dopamine mesebetsing ea makoloi e susumetsoang ke tlhahiso ea lijo ea nako le nako: tlhahlobo ea microdialysis le boithuto ba boits'oaro. Lipatlisiso tsa boko. 1992;592(12): 29-36. [E fetotsoe]
178. Sinha R, Lacadie C, Skudlarski P, Fulbright RK, Rounsaville BJ, Kosten TR, le al. Ketsahalo ea Neural e amanang le takatso ea khatello ea k'hok'heine e bakoang ke khatello ea maikutlo: boithuto bo sebetsang ba ho nka litšoantšo tsa matla a khoheli. Psychopharmacology (Berl) 2005;183(2): 171-80. [E fetotsoe]
179. Muraven M, Baumeister RF. Boitlhopho le ho felloa ke lisebelisoa tse fokolang: na boitšoaro bo tšoana le mosifa? Litaba tsa kelello. 2000;126(2): 247-59. [E fetotsoe]
180. Brewer JA, Grant JE, Potenza MN. Neurobiology ea Papali ea papali ea chelete. Ka: Smith G, Hodgins D, Williams R, bahlophisi. Litaba tsa Patlisiso le Tekanyo Lithutong tsa Ho becha. Elsivier; San Diego: Tlalehong.
181. Meyer G, Hauffa BP, Schedlowski M, Pawlak C, Stadler MA, Exton MS. Ho becha ha Casino ho eketsa ho otla ha pelo le "salivary cortisol" ho batho ba tloaetseng ho becha. Likokoana-hloko tsa likokoana-hloko. 2000;48(9): 948-953. [E fetotsoe]
182. Krueger THC, Schedlowski M, Meyer G. Cortisol le Mehato ea Palo ea Pelo nakong ea Papali ea Chelete ea Casino Kamanong le Ts'oaetso. Neuropsychobiology. 2005;52(4): 206-211. [E fetotsoe]
183. Meyer G, Schwertfeger J, Exton MS, Janssen OE, Knapp W, Stadler MA, le al. Karabelo ea Neuroendocrine ho becha ea casino ho ba nang le bothata ba papali ea chelete. Psychoneuroendocrinology. 2004;29(10): 1272-1280. [E fetotsoe]
184. Johnson SW, North RA. Opioids e khahlisa li-dopamine neurons ka hyperpolarization ea li-interneurons tsa lehae. J Neurosci. 1992;12(2): 483-488. [E fetotsoe]
185. Margolis EB, Hjelmstad GO, Bonci A, Masimo HL. Kappa-opioid agonists e thibela ka kotloloho li-midbrain dopaminergic neurons. Leqephe la Neuroscience. 2003;23(31): 9981-6. [E fetotsoe]
186. Ford CP, Mark GP, Williams JT. Thepa le thibelo ea opioid ea mesolimbic dopamine neurons e fapana ho ea ka sebaka se shebiloeng. Leqephe la Neuroscience. 2006;26(10): 2788-97. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
187. Holo ea FS, Li XF, Goeb M, Roff S, Hoggatt H, Sora I, et al. Congenic C57BL / 6 mu opiate receptor (MOR) litoeba tsa ho kokota: litlamorao tsa mantlha le tsa opiate. Tsoalo, kelello le boitšoaro. 2003;2(2): 114-21. [E fetotsoe]
188. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, le al. Single-nucleotide polymorphism ho motho ea opioid receptor gene e fetola beta-endorphin tlamo le ts'ebetso: litlamorao tse ka bang teng ho lemaleng ha opiate. Ts'ebetso ea Setsi sa Naha sa Mahlale sa United States of America. 1998;95(16): 9608-13. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
189. Oslin DW, Berrettini WH, O'Brien CP. Sepheo sa kalafo bakeng sa ts'ebeliso ea joala: pharmacogenetics ea naltrexone. Likokoana-hloko tsa likokoana-hloko. 2006;11(34): 397-403. [E fetotsoe]
190. Shinohara K, Yanagisawa A, Kagota Y, Gomi A, Nemoto K, Moriya E, et al. Liphetoho tsa 'mele ho libapali tsa Pachinko; beta-endorphin, catecholamine, immune system le ho otla ha pelo. Appl ea Saense ea Batho. 1999;18(2): 37-42. [E fetotsoe]
191. Tamminga CA, Nestler EJ. Ho becha ka bolotsana: ho shebana le bokhoba, eseng ketsahalo. Am J Psychiatry. 2006;163(2): 180-1. [E fetotsoe]
192. O'Brien CP. Meriana e thibelang ho thibela tšoaetso hape: sehlopha se secha sa meriana e tlatsetsang. Am J Psychiatry. 2005;162(8): 1423-31. [E fetotsoe]
193. Kim SW, Grant JE, Adson DE, Shin YC. Ka bobeli-o foufetse naltrexone le phapang ea li-placebo ea ho phekola papali ea chelete. Biol Psychiatry. 2001;49(11): 914-21. [E fetotsoe]
194. Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, et al. Lipatlisiso tse ngata tsa antio ea antio ea agio e sebelisang kalafo ea ho becha. Am J Psychiatry. 2006;163(2): 303-12. [E fetotsoe]
195. Raymond NC, Grant JE, Kim SW, Coleman E. Kalafo ea boitšoaro bo hlephileng ba thobalano le naltrexone le serotonin reuptake inhibitors: lithuto tse peli tsa linyeoe. Clinical psychopharmacology ea machabeng. 2002;17(4): 201-5. [E fetotsoe]
196. Ho khutlisa RyS. Naltrexone ea ho phekola batloli ba thobalano ba lilemong tsa bocha. Journal ea mafu a mafu a kelello. 2004;65(7): 982-6. [E fetotsoe]
197. Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing Schizophrenia: Kakaretso ea Ts'ebeliso ea Endophenotypes molemong oa ho utloisisa bothata bo rarahaneng. Schizophr Bull. 2007;33(1): 21-32. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
198. Gottesman II, Gould TD. Khopolo ea Endophenotype ho Psychiatry: Etymology le Morero oa Morero. Am J Psychiatry. 2003;160(4): 636-645. [E fetotsoe]